data_1i6g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i6g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 16' ' ' VAL . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.421 ' OH ' HD23 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.513 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 42' ' ' CYS . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' O ' ' HE2' ' A' ' 1' ' ' LYS . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.542 ' HG2' ' CG2' ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' LEU . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.47 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB2' ' OD1' ' A' ' 19' ' ' ASN . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ALA . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.449 ' OD1' ' SD ' ' A' ' 27' ' ' MET . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 31' ' ' SER . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.465 ' HB2' HD11 ' A' ' 45' ' ' LEU . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 1' ' ' LYS . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.484 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.505 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.427 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 6.2 t . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG23 ' HG2' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HG2' ' CB ' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' SER . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.519 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.43 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CA ' ' O ' ' A' ' 4' ' ' TYR . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 14' ' ' SER . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 13' ' ' LEU . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' A' ' 24' ' ' GLN . 7.4 tp-100 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' HD2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.0 p-80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HG2' ' CB ' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' CB ' ' HG2' ' A' ' 46' ' ' PRO . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 17' ' ' ALA . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 42' ' ' CYS . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.562 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 44' ' ' GLY . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HA ' HG11 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD22 ' OH ' ' A' ' 20' ' ' TYR . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' OH ' HD22 ' A' ' 13' ' ' LEU . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.6 p-80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.424 ' OE1' ' CG ' ' A' ' 2' ' ' ASP . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 1' ' ' LYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' O ' ' HE2' ' A' ' 1' ' ' LYS . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 45' ' ' LEU . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 6.7 p80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 1' ' ' LYS . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 50' ' ' LYS . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 9' ' ' LYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.467 ' HE3' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 13.2 p30 -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.402 ' C ' HG11 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.507 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.525 ' CG2' ' HD2' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.518 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 2.4 p-80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.525 ' HD2' ' CG2' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.572 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD21 ' OH ' ' A' ' 20' ' ' TYR . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CE1' ' CD2' ' A' ' 41' ' ' TYR . 9.3 p-80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' LYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.46 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 1' ' ' LYS . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.526 ' CG ' HG21 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' CE ' ' A' ' 1' ' ' LYS . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.473 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HB3' ' HE3' ' A' ' 28' ' ' LYS . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD22 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HA ' HG11 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' C ' ' OD1' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' A' ' 10' ' ' GLY . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD23 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' OH ' HD23 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 1' ' ' LYS . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.542 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.421 HD23 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 16' ' ' VAL . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.421 ' OH ' HD23 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.513 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 42' ' ' CYS . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' O ' ' HE2' ' A' ' 1' ' ' LYS . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.542 ' HG2' ' CG2' ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t -90.76 174.2 7.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.0 28.94 7.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 p -156.73 170.17 23.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -87.2 15.07 6.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.126 -0.984 . . . . 0.0 110.216 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.38 140.0 20.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.843 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 13.3 p30 -115.87 -179.3 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 mm -105.36 60.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 110.706 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.481 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -79.72 170.55 16.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.896 179.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 1' ' ' LYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -90.7 143.38 26.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -111.48 40.81 2.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.085 -1.01 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 57' ' ' ASN . 53.6 p -153.7 129.43 10.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.406 ' O ' HG21 ' A' ' 56' ' ' THR . . . -83.23 6.34 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.53 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 55' ' ' ALA . 27.6 p -144.62 75.79 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 110.47 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 5.7 p-10 -159.06 120.13 3.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 59' ' ' CYS . 16.5 mt -117.15 146.41 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.485 ' N ' HG23 ' A' ' 58' ' ' ILE . 28.6 p -110.04 145.49 36.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.116 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.525 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 45' ' ' LEU . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.47 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB2' ' OD1' ' A' ' 19' ' ' ASN . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ALA . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' OD1' ' SD ' ' A' ' 27' ' ' MET . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.547 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 31' ' ' SER . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -89.85 167.02 13.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -134.14 27.79 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.148 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 p -140.05 131.52 26.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.54 8.49 33.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 110.387 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 t -142.88 54.71 1.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.0 110.768 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -132.39 153.03 51.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 110.053 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.19 131.01 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' GLY . 38.4 t -109.31 114.51 28.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 59' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 117.962 -1.465 . . . . 0.0 109.485 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.451 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.465 ' HB2' HD11 ' A' ' 45' ' ' LEU . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 1' ' ' LYS . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t -87.6 148.83 24.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.98 8.8 34.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.2 p -149.03 121.94 8.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.9 -12.79 12.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.01 56.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -94.88 124.44 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.86 90.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 0.0 110.219 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 26.0 p -110.6 89.22 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 110.255 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.613 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.566 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.446 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.497 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.454 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.566 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.484 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.505 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.427 ' HB2' ' CG1' ' A' ' 6' ' ' VAL . 6.2 t -90.14 133.24 35.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.97 18.76 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.747 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.5 p -121.2 99.45 6.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.067 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.81 17.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.5 m -122.6 73.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.454 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -149.34 138.31 21.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -139.08 117.26 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.472 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.443 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 24.6 p -99.2 100.1 11.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.63 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG23 ' HG2' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 54' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 30' ' ' ALA . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.49 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.497 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.497 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HG2' ' CB ' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.404 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t -90.3 150.36 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -105.45 29.0 6.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.961 . . . . 0.0 110.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . 98.3 p -156.5 163.25 39.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.289 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.08 -5.37 56.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.398 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -172.9 3.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 3.0 p-10 -103.27 124.28 48.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 110.5 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.2 tt -129.64 84.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -167.38 1.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' SER . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.43 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.452 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.483 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CA ' ' O ' ' A' ' 4' ' ' TYR . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 148.07 35.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 53' ' ' ASP . 49.1 p30 -112.38 15.09 20.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 2.4 p -128.06 112.91 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.02 18.09 6.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.249 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.7 p -150.08 55.54 0.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.991 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 19.5 p-10 -160.12 130.2 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.259 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 1.5 tp -101.29 114.63 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.819 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 29.4 p -81.29 143.37 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.977 -1.077 . . . . 0.0 110.445 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HB3' ' HE2' ' A' ' 28' ' ' LYS . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 54' ' ' SER . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' O ' ' C ' ' A' ' 14' ' ' SER . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 13' ' ' LEU . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' A' ' 24' ' ' GLN . 7.4 tp-100 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' HD2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t -89.3 141.52 28.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 53' ' ' ASP . 16.5 p30 -99.1 32.14 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.475 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 5.0 p -154.56 148.17 25.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.12 -18.38 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.991 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -123.85 116.38 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.898 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 8.6 p30 -102.07 170.86 7.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.363 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.87 51.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.425 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 49.3 t -84.45 127.53 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 46' ' ' PRO . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.0 p-80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HG2' ' CB ' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' CB ' ' HG2' ' A' ' 46' ' ' PRO . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.532 ' O ' ' CG2' ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -81.63 156.02 25.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -108.09 6.48 26.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.201 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -147.1 147.97 31.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 110.364 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.27 -17.51 63.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.977 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.78 177.89 6.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.797 . . . . 0.0 110.173 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 7.9 p-10 -82.46 91.7 6.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.167 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 58' ' ' ILE . 4.9 tp -97.42 60.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 74.05 5.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.855 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 17' ' ' ALA . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 18' ' ' ASN . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 42' ' ' CYS . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.486 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -87.79 127.12 35.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.15 25.66 2.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 110.393 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.7 p -155.93 145.0 20.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.78 14.91 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.148 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -135.78 75.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -118.82 174.81 6.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.051 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.73 110.63 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 110.777 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 60' ' ' GLY . 11.0 t -79.66 107.35 12.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.036 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 59' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.447 HG22 ' HG2' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.562 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 44' ' ' GLY . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t -90.45 133.42 35.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 17.0 p-10 -87.8 21.56 2.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -133.54 122.42 23.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 110.232 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -15.6 50.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.138 -0.977 . . . . 0.0 110.506 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' HG21 ' A' ' 56' ' ' THR . 2.5 t -144.81 112.0 6.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.242 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 21.7 p-10 -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 59' ' ' CYS . 51.6 mt -97.22 144.24 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 44.1 t -108.82 119.12 38.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.163 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.613 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HA ' HG11 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD22 ' OH ' ' A' ' 20' ' ' TYR . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 39' ' ' SER . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' OH ' HD22 ' A' ' 13' ' ' LEU . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.6 p-80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.424 ' OE1' ' CG ' ' A' ' 2' ' ' ASP . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 1' ' ' LYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' O ' ' HE2' ' A' ' 1' ' ' LYS . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -84.56 175.51 9.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -125.7 16.74 8.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.748 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 56' ' ' THR . 24.1 p -150.33 148.76 29.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.054 -1.029 . . . . 0.0 110.167 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.89 67.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.881 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -130.65 141.1 50.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 57' ' ' ASN . 1.2 p30 -145.83 179.84 7.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 58' ' ' ILE . 11.4 mt -114.86 56.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.988 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 10.4 t -116.52 139.57 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.431 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 118.078 -1.401 . . . . 0.0 109.65 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 45' ' ' LEU . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.438 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 6.7 p80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.548 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 1' ' ' LYS . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' HG12 ' A' ' 51' ' ' VAL . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 50' ' ' LYS . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t -88.36 155.96 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.37 45.87 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.099 -1.001 . . . . 0.0 110.322 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.493 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 89.0 p -156.43 125.15 5.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.036 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' O ' HG21 ' A' ' 56' ' ' THR . . . -89.64 9.74 25.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.532 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 55' ' ' ALA . 72.3 p -138.33 69.91 1.38 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.988 . . . . 0.0 110.337 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.493 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 38.2 p-10 -159.24 156.35 28.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.242 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.15 162.95 21.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.564 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 9' ' ' LYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.467 ' HA ' ' HE3' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.467 ' HE3' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD2' ' HB3' ' A' ' 28' ' ' LYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 13.2 p30 -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.489 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.402 ' C ' HG11 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t -90.13 123.33 33.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.89 5.16 16.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 4.5 p -117.76 126.1 51.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.113 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.82 -0.29 38.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 53.7 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 110.272 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 15.1 p-10 -109.07 174.48 5.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 0.0 109.894 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.86 134.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.198 -0.939 . . . . 0.0 110.516 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.1 t -92.45 -139.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.015 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.514 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.507 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.535 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.429 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.507 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.525 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -90.31 158.12 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.58 12.83 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.986 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -109.53 126.32 53.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.64 37.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.373 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.35 95.23 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.485 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 11.9 p-10 -150.89 170.47 19.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 109.85 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.56 150.63 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.056 -1.028 . . . . 0.0 110.612 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.1 p -121.97 -165.58 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.671 179.847 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 ' CG2' ' HD2' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.502 ' CD ' ' OD1' ' A' ' 57' ' ' ASN . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.437 HD22 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.518 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 2.4 p-80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.474 ' HB3' ' CB ' ' A' ' 49' ' ' ALA . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.525 ' HD2' ' CG2' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t -86.62 136.44 33.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.81 23.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.406 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -153.57 135.45 14.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.452 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -69.56 -5.23 23.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.81 . . . . 0.0 110.023 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -141.84 107.2 5.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.873 . . . . 0.0 110.328 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' OD1' ' CD ' ' A' ' 12' ' ' LYS . 13.6 p-10 -143.84 174.71 10.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.44 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 59' ' ' CYS . 91.7 mt -138.52 153.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.443 ' N ' HG22 ' A' ' 58' ' ' ILE . 25.6 p -140.82 83.9 1.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.542 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.572 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.526 HG21 ' CG ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD21 ' OH ' ' A' ' 20' ' ' TYR . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 30' ' ' ALA . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 25' ' ' CYS . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CE1' ' CD2' ' A' ' 41' ' ' TYR . 9.3 p-80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 1' ' ' LYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.46 ' HB2' ' OD1' ' A' ' 48' ' ' ASN . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 1' ' ' LYS . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' CG ' HG21 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' CE ' ' A' ' 1' ' ' LYS . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t -91.19 122.15 33.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 20.7 p-10 -86.13 31.95 0.63 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.127 -0.983 . . . . 0.0 110.365 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p -157.68 153.82 27.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.57 29.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.285 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.3 m -85.62 141.44 29.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 12.7 p30 -87.17 152.57 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.42 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.0 tt -131.59 51.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.924 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 t -89.29 41.58 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.459 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.473 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HB3' ' HE3' ' A' ' 28' ' ' LYS . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD22 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB3' HD23 ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.523 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 ' CD1' ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -85.24 158.37 20.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 21.4 p-10 -115.47 14.49 16.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.467 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 p -121.74 115.39 22.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.5 5.69 12.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.6 t -140.74 65.51 1.4 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.442 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -144.8 161.23 39.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.15 133.77 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.393 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.4 p -103.82 147.36 27.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.543 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HA ' HG11 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HE2' ' OD1' ' A' ' 57' ' ' ASN . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.497 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' C ' ' OD1' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t -90.37 121.95 32.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 14.3 p-10 -87.67 28.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 86.8 p -132.59 95.61 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.998 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.19 3.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.941 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -120.43 82.08 1.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.466 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 1.3 p-10 -145.78 172.33 13.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.088 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.412 HG12 ' N ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -139.92 155.9 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 110.459 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.412 ' N ' HG12 ' A' ' 58' ' ' ILE . 6.3 t -137.51 132.5 33.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.487 HG22 ' HA2' ' A' ' 10' ' ' GLY . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' HG22 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD23 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' OH ' HD23 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 1' ' ' LYS . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 45' ' ' LEU . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.433 ' ND2' ' HB2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' C ' HG12 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 4' ' ' TYR . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t -81.82 144.78 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -96.92 7.31 46.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 p -134.46 144.4 48.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -28.92 40.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -91.72 145.57 24.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.086 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -83.64 122.47 28.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 mm -106.96 63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 110.147 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.89 29.29 7.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.212 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.614 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.6 HD21 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.6 ' OH ' HD21 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 51' ' ' VAL . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 42' ' ' CYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 6' ' ' VAL . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' CD ' ' O ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.609 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 HG11 ' A' ' 51' ' ' VAL . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 45' ' ' LEU . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.622 ' HE3' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.566 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 13' ' ' LEU . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.476 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' SER . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 51' ' ' VAL . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 45' ' ' LEU . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 43' ' ' GLU . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.554 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.649 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' OH ' HD21 ' A' ' 13' ' ' LEU . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.458 ' O ' ' CD2' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.554 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.728 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.838 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 45' ' ' LEU . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 12' ' ' LYS . 6.2 t . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 51' ' ' VAL . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.63 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.63 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.945 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 5' ' ' PRO . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 ' OH ' ' A' ' 20' ' ' TYR . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 51' ' ' VAL . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 5' ' ' PRO . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.55 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 50' ' ' LYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.575 HD11 ' OH ' ' A' ' 20' ' ' TYR . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.575 ' OH ' HD11 ' A' ' 13' ' ' LEU . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 27' ' ' MET . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 25' ' ' CYS . 40.0 tp60 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.665 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.759 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.76 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.761 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.575 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.761 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.985 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 45' ' ' LEU . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 50' ' ' LYS . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.591 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.639 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.639 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.591 ' OH ' HD21 ' A' ' 13' ' ' LEU . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.724 HD13 HG11 ' A' ' 51' ' ' VAL . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.908 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.908 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG11 HD13 ' A' ' 45' ' ' LEU . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 51' ' ' VAL . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' MET . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 51' ' ' VAL . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 45' ' ' LEU . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 50' ' ' LYS . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 38' ' ' MET . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 17' ' ' ALA . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 3.7 p80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.664 ' HB2' HD21 ' A' ' 45' ' ' LEU . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 42' ' ' CYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.695 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 5' ' ' PRO . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 20' ' ' TYR . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.845 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.845 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.698 ' HE1' ' HD2' ' A' ' 41' ' ' TYR . 29.6 p-80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.698 ' HD2' ' HE1' ' A' ' 34' ' ' HIS . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 5' ' ' PRO . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HA ' ' HE2' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 42' ' ' CYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.771 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 5' ' ' PRO . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.589 HG12 ' HD2' ' A' ' 20' ' ' TYR . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HD2' HG12 ' A' ' 16' ' ' VAL . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' CYS . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.815 HD21 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.757 ' HB1' ' ND2' ' A' ' 19' ' ' ASN . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.757 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.815 ' OH ' HD21 ' A' ' 13' ' ' LEU . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.019 HD13 HG11 ' A' ' 51' ' ' VAL . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.019 HG11 HD13 ' A' ' 45' ' ' LEU . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' GLN . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 42' ' ' CYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.756 ' O ' HG22 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.653 HD21 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.653 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.858 ' HB2' HD11 ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 50' ' ' LYS . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.681 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 51' ' ' VAL . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 45' ' ' LEU . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.825 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HA ' HG12 ' A' ' 6' ' ' VAL . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.574 HD21 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' ND2' ' SD ' ' A' ' 27' ' ' MET . 0.4 OUTLIER -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.491 ' SD ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 51' ' ' VAL . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.8 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.8 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 5' ' ' PRO . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD21 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.6 ' OH ' HD21 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 51' ' ' VAL . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t -90.76 174.2 7.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.0 28.94 7.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 p -156.73 170.17 23.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -87.2 15.07 6.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.126 -0.984 . . . . 0.0 110.216 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.38 140.0 20.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.843 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 13.3 p30 -115.87 -179.3 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 mm -105.36 60.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 110.706 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.481 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -79.72 170.55 16.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.896 179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE3' ' OD1' ' A' ' 57' ' ' ASN . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 42' ' ' CYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 6' ' ' VAL . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -90.7 143.38 26.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -111.48 40.81 2.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.085 -1.01 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 57' ' ' ASN . 53.6 p -153.7 129.43 10.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 6.34 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.53 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 p -144.62 75.79 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 110.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 5.7 p-10 -159.06 120.13 3.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mt -117.15 146.41 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.6 p -110.04 145.49 36.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.116 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.525 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' CD ' ' O ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.609 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 HG11 ' A' ' 51' ' ' VAL . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 45' ' ' LEU . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -89.85 167.02 13.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -134.14 27.79 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.148 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 p -140.05 131.52 26.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.54 8.49 33.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 110.387 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 t -142.88 54.71 1.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.0 110.768 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -132.39 153.03 51.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 110.053 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.19 131.01 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' GLY . 38.4 t -109.31 114.51 28.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 117.962 -1.465 . . . . 0.0 109.485 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.622 ' HE3' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.566 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 13' ' ' LEU . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.476 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' SER . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 51' ' ' VAL . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 45' ' ' LEU . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t -87.6 148.83 24.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.98 8.8 34.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.2 p -149.03 121.94 8.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.9 -12.79 12.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.01 56.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -94.88 124.44 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 58' ' ' ILE . 2.2 mp -123.86 90.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 59' ' ' CYS . 26.0 p -110.6 89.22 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 110.255 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.613 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 43' ' ' GLU . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.554 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.649 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' OH ' HD21 ' A' ' 13' ' ' LEU . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' O ' ' CD2' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.554 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.728 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.838 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 45' ' ' LEU . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 12' ' ' LYS . 6.2 t -90.14 133.24 35.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.97 18.76 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.747 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.5 p -121.2 99.45 6.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.067 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.81 17.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 56' ' ' THR . 47.5 m -122.6 73.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.454 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -149.34 138.31 21.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -139.08 117.26 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.472 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 59' ' ' CYS . 24.6 p -99.2 100.1 11.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.63 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 51' ' ' VAL . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.63 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.63 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.945 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 5' ' ' PRO . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t -90.3 150.36 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -105.45 29.0 6.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.961 . . . . 0.0 110.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.3 p -156.5 163.25 39.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.289 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.08 -5.37 56.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.398 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -172.9 3.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -103.27 124.28 48.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 110.5 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.2 tt -129.64 84.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -167.38 1.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 ' OH ' ' A' ' 20' ' ' TYR . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 51' ' ' VAL . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 5' ' ' PRO . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 148.07 35.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 53' ' ' ASP . 49.1 p30 -112.38 15.09 20.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 2.4 p -128.06 112.91 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.461 ' C ' HG23 ' A' ' 56' ' ' THR . . . -90.02 18.09 6.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.249 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 55' ' ' ALA . 61.7 p -150.08 55.54 0.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.991 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 19.5 p-10 -160.12 130.2 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.259 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 58' ' ' ILE . 1.5 tp -101.29 114.63 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.819 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 29.4 p -81.29 143.37 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.977 -1.077 . . . . 0.0 110.445 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.55 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 50' ' ' LYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 54' ' ' SER . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.575 HD11 ' OH ' ' A' ' 20' ' ' TYR . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.575 ' OH ' HD11 ' A' ' 13' ' ' LEU . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 27' ' ' MET . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 25' ' ' CYS . 40.0 tp60 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.665 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.759 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.76 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t -89.3 141.52 28.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 53' ' ' ASP . 16.5 p30 -99.1 32.14 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.504 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 5.0 p -154.56 148.17 25.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.12 -18.38 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.991 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -123.85 116.38 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.898 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 8.6 p30 -102.07 170.86 7.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.363 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 58' ' ' ILE . 3.3 mp -109.87 51.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 49.3 t -84.45 127.53 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.761 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.575 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.761 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.985 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 45' ' ' LEU . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -81.63 156.02 25.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -108.09 6.48 26.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.201 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -147.1 147.97 31.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 110.364 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.27 -17.51 63.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.977 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.78 177.89 6.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.797 . . . . 0.0 110.173 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 7.9 p-10 -82.46 91.7 6.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.167 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 58' ' ' ILE . 4.9 tp -97.42 60.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 74.05 5.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.855 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 50' ' ' LYS . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.591 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.639 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.639 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.591 ' OH ' HD21 ' A' ' 13' ' ' LEU . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.724 HD13 HG11 ' A' ' 51' ' ' VAL . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.908 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.908 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG11 HD13 ' A' ' 45' ' ' LEU . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -87.79 127.12 35.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.15 25.66 2.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 110.393 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.7 p -155.93 145.0 20.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.78 14.91 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.148 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -135.78 75.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -118.82 174.81 6.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.051 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.73 110.63 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 110.777 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 60' ' ' GLY . 11.0 t -79.66 107.35 12.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.036 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 59' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 51' ' ' VAL . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' MET . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 51' ' ' VAL . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 45' ' ' LEU . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t -90.45 133.42 35.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 17.0 p-10 -87.8 21.56 2.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -133.54 122.42 23.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 110.232 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -15.6 50.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.138 -0.977 . . . . 0.0 110.506 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 56' ' ' THR . 2.5 t -144.81 112.0 6.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.242 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 21.7 p-10 -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt -97.22 144.24 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 44.1 t -108.82 119.12 38.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.163 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.613 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 50' ' ' LYS . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 38' ' ' MET . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 17' ' ' ALA . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 3.7 p80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.664 ' HB2' HD21 ' A' ' 45' ' ' LEU . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 42' ' ' CYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.695 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 5' ' ' PRO . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -84.56 175.51 9.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -125.7 16.74 8.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.748 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 p -150.33 148.76 29.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.054 -1.029 . . . . 0.0 110.167 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.89 67.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.881 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 141.1 50.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -145.83 179.84 7.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 58' ' ' ILE . 11.4 mt -114.86 56.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.988 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 10.4 t -116.52 139.57 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.431 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 118.078 -1.401 . . . . 0.0 109.65 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 20' ' ' TYR . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.845 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.845 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.698 ' HE1' ' HD2' ' A' ' 41' ' ' TYR . 29.6 p-80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.698 ' HD2' ' HE1' ' A' ' 34' ' ' HIS . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 5' ' ' PRO . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t -88.36 155.96 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.37 45.87 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.099 -1.001 . . . . 0.0 110.322 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.493 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 89.0 p -156.43 125.15 5.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.036 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.64 9.74 25.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.532 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -138.33 69.91 1.38 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.988 . . . . 0.0 110.337 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.493 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 38.2 p-10 -159.24 156.35 28.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.15 162.95 21.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.564 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HA ' ' HE2' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 42' ' ' CYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.563 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 0.3 OUTLIER -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.771 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 5' ' ' PRO . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t -90.13 123.33 33.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.89 5.16 16.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 4.5 p -117.76 126.1 51.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.113 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.82 -0.29 38.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 53.7 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 110.272 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 15.1 p-10 -109.07 174.48 5.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 0.0 109.894 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.86 134.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.198 -0.939 . . . . 0.0 110.516 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.1 t -92.45 -139.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.015 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.514 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.589 HG12 ' HD2' ' A' ' 20' ' ' TYR . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HD2' HG12 ' A' ' 16' ' ' VAL . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.535 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' CYS . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -90.31 158.12 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.58 12.83 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.986 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -109.53 126.32 53.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.64 37.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.373 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.35 95.23 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.485 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 11.9 p-10 -150.89 170.47 19.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 109.85 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.56 150.63 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.056 -1.028 . . . . 0.0 110.612 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.1 p -121.97 -165.58 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.671 179.847 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.502 ' CD ' ' OD1' ' A' ' 57' ' ' ASN . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.815 HD21 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.757 ' HB1' ' ND2' ' A' ' 19' ' ' ASN . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.757 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.815 ' OH ' HD21 ' A' ' 13' ' ' LEU . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.019 HD13 HG11 ' A' ' 51' ' ' VAL . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.019 HG11 HD13 ' A' ' 45' ' ' LEU . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t -86.62 136.44 33.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.81 23.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.406 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -153.57 135.45 14.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.452 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -69.56 -5.23 23.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.81 . . . . 0.0 110.023 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -141.84 107.2 5.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.873 . . . . 0.0 110.328 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' OD1' ' CD ' ' A' ' 12' ' ' LYS . 13.6 p-10 -143.84 174.71 10.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.44 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.7 mt -138.52 153.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 59' ' ' CYS . 25.6 p -140.82 83.9 1.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.542 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' GLN . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 42' ' ' CYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.756 ' O ' HG22 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t -91.19 122.15 33.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 20.7 p-10 -86.13 31.95 0.63 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.127 -0.983 . . . . 0.0 110.365 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p -157.68 153.82 27.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.57 29.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.285 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.3 m -85.62 141.44 29.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 12.7 p30 -87.17 152.57 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.42 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 58' ' ' ILE . 3.0 tt -131.59 51.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.924 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 t -89.29 41.58 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.653 HD21 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.653 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.858 ' HB2' HD11 ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -85.24 158.37 20.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 21.4 p-10 -115.47 14.49 16.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.467 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 p -121.74 115.39 22.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.5 5.69 12.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 56' ' ' THR . 8.6 t -140.74 65.51 1.4 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.442 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -144.8 161.23 39.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.15 133.77 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.393 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.4 p -103.82 147.36 27.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.543 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 50' ' ' LYS . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE2' ' OD1' ' A' ' 57' ' ' ASN . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.681 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 51' ' ' VAL . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 45' ' ' LEU . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t -90.37 121.95 32.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 14.3 p-10 -87.67 28.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 86.8 p -132.59 95.61 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.998 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.19 3.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.941 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -120.43 82.08 1.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 1.3 p-10 -145.78 172.33 13.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.088 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG12 ' N ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -139.92 155.9 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 110.459 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 58' ' ' ILE . 6.3 t -137.51 132.5 33.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.825 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HA ' HG12 ' A' ' 6' ' ' VAL . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.574 HD21 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' ND2' ' SD ' ' A' ' 27' ' ' MET . 0.4 OUTLIER -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.491 ' SD ' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 51' ' ' VAL . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.8 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.8 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 5' ' ' PRO . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t -81.82 144.78 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -96.92 7.31 46.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 p -134.46 144.4 48.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -28.92 40.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -91.72 145.57 24.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.086 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -83.64 122.47 28.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 mm -106.96 63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 110.147 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.89 29.29 7.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.212 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.614 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.6 HD21 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.6 ' OH ' HD21 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 51' ' ' VAL . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 42' ' ' CYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 6' ' ' VAL . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.609 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 HG11 ' A' ' 51' ' ' VAL . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 45' ' ' LEU . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t . . . . . 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.622 ' HE3' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.566 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 13' ' ' LEU . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.476 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' SER . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 51' ' ' VAL . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 45' ' ' LEU . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 43' ' ' GLU . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.554 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.649 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' OH ' HD21 ' A' ' 13' ' ' LEU . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.554 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.728 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.838 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 45' ' ' LEU . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 12' ' ' LYS . 6.2 t . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 51' ' ' VAL . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.63 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.63 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.945 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 5' ' ' PRO . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 ' OH ' ' A' ' 20' ' ' TYR . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 51' ' ' VAL . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 5' ' ' PRO . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.55 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 50' ' ' LYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.575 HD11 ' OH ' ' A' ' 20' ' ' TYR . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.575 ' OH ' HD11 ' A' ' 13' ' ' LEU . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 27' ' ' MET . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 24' ' ' GLN . 7.4 tp-100 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.665 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.759 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.76 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.761 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.575 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.0 p-80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.575 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.761 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.985 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 45' ' ' LEU . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 50' ' ' LYS . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.591 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.639 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.639 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.591 ' OH ' HD21 ' A' ' 13' ' ' LEU . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.724 HD13 HG11 ' A' ' 51' ' ' VAL . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.908 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.908 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG11 HD13 ' A' ' 45' ' ' LEU . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 51' ' ' VAL . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' MET . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 51' ' ' VAL . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 45' ' ' LEU . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 50' ' ' LYS . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 38' ' ' MET . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 17' ' ' ALA . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.6 p-80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.664 ' HB2' HD21 ' A' ' 45' ' ' LEU . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 42' ' ' CYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.695 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 5' ' ' PRO . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 20' ' ' TYR . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.845 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.845 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 6.7 p80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.547 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 5' ' ' PRO . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HA ' ' HE2' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 42' ' ' CYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 13.2 p30 -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.771 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 5' ' ' PRO . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.589 HG12 ' HD2' ' A' ' 20' ' ' TYR . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HD2' HG12 ' A' ' 16' ' ' VAL . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.535 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' CYS . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.815 HD21 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.757 ' HB1' ' ND2' ' A' ' 19' ' ' ASN . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.757 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.815 ' OH ' HD21 ' A' ' 13' ' ' LEU . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 2.4 p-80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.019 HD13 HG11 ' A' ' 51' ' ' VAL . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.019 HG11 HD13 ' A' ' 45' ' ' LEU . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.572 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' GLN . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CE1' ' CD2' ' A' ' 41' ' ' TYR . 9.3 p-80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 42' ' ' CYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.756 ' O ' HG22 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.653 HD21 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.653 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.858 ' HB2' HD11 ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 50' ' ' LYS . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.681 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 51' ' ' VAL . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.416 ' C ' ' OD1' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 45' ' ' LEU . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.825 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HA ' HG12 ' A' ' 6' ' ' VAL . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.574 HD21 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 51' ' ' VAL . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.8 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.8 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 5' ' ' PRO . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 62.3 pttt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.334 0.588 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 5.2 m-20 -126.96 158.9 35.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 41' ' ' TYR . . . 165.46 -170.37 40.33 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.253 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.1 m-85 -104.42 119.99 52.07 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.997 . . . . 0.0 109.487 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 45.5 Cg_endo -70.29 140.77 41.45 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.827 1.435 . . . . 0.0 110.826 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 50' ' ' LYS . 17.4 m -107.54 -177.83 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.399 -0.813 . . . . 0.0 110.641 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 3.2 p30 -106.75 -164.53 1.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.591 -0.693 . . . . 0.0 110.49 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.3 p -59.69 -19.22 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.369 -0.832 . . . . 0.0 110.772 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -97.18 -18.54 19.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.546 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.04 17.44 25.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 19.4 m -94.82 144.65 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.422 -1.046 . . . . 0.0 109.966 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' NZ ' ' O ' ' A' ' 55' ' ' ALA . 2.3 mtmt -55.99 145.76 24.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.97 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.6 HD21 ' OH ' ' A' ' 20' ' ' TYR . 15.6 tp -79.46 117.63 20.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.179 -0.951 . . . . 0.0 110.284 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.0 OUTLIER -67.31 105.68 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 110.036 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.2 p -94.67 153.86 17.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 110.157 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -127.91 -6.36 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -159.24 155.7 27.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.006 . . . . 0.0 110.616 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -66.28 -48.07 71.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.175 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 20.8 p-10 -49.93 -45.51 51.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.253 -0.904 . . . . 0.0 110.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.6 ' OH ' HD21 ' A' ' 13' ' ' LEU . 19.2 t80 -54.9 -61.42 2.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 m -59.42 -46.12 89.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.296 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -47.14 -43.82 21.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.201 -0.937 . . . . 0.0 110.138 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.41 -48.17 57.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.989 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 25' ' ' CYS . 19.3 tp60 -57.42 -63.11 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.911 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.501 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 74.3 m -43.6 -53.68 5.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 110.037 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -43.85 -62.3 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.8 mtp -46.78 -31.42 2.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 0.0 110.158 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -90.67 43.25 1.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 0.0 110.565 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 4.1 tttp 43.91 27.36 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.314 -0.866 . . . . 0.0 110.874 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -95.93 -176.39 3.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.17 -0.956 . . . . 0.0 110.036 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.5 t -139.43 -36.95 0.51 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 0.0 110.571 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -106.38 89.13 0.58 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -106.96 111.13 3.43 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 8.1 p-80 -141.04 164.17 31.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.404 -1.057 . . . . 0.0 110.43 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.0 111.02 23.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.385 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.1 t80 -119.54 122.21 41.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.78 45.58 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 110.128 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.1 mtt 59.23 11.98 2.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.79 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.3 m -118.01 133.95 55.43 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.946 -1.096 . . . . 0.0 109.822 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.3 t -78.57 142.77 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.501 ' CE2' ' HA2' ' A' ' 3' ' ' GLY . 54.6 t80 -143.07 124.0 14.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 110.132 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 27.9 m -109.44 139.08 44.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.4 108.31 19.6 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.457 -0.777 . . . . 0.0 109.662 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.39 14.06 5.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 51' ' ' VAL . 14.6 mt -57.53 164.49 2.84 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.343 -1.093 . . . . 0.0 110.18 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.99 144.77 38.74 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 O-C-N 124.057 1.556 . . . . 0.0 109.778 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 11.7 tt0 -49.93 -20.08 0.83 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 110.644 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -105.49 20.86 18.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.02 -1.05 . . . . 0.0 110.836 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.73 157.68 23.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.019 -1.051 . . . . 0.0 109.683 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.71 ' O ' HG22 ' A' ' 6' ' ' VAL . 36.0 tttm -104.35 77.05 1.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.858 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.9 m -117.55 166.82 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.324 -0.86 . . . . 0.0 110.583 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 t -90.76 174.2 7.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.513 -0.742 . . . . 0.0 110.148 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.0 28.94 7.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.207 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.8 p -156.73 170.17 23.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.892 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -87.2 15.07 6.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.126 -0.984 . . . . 0.0 110.216 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.38 140.0 20.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.843 . . . . 0.0 110.186 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 13.3 p30 -115.87 -179.3 3.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 110.148 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.7 mm -105.36 60.73 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -0.918 . . . . 0.0 110.706 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.481 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -79.72 170.55 16.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.045 -1.034 . . . . 0.0 109.896 179.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' LEU . 38.4 pttt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.253 0.549 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -101.9 149.97 23.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.287 -0.883 . . . . 0.0 109.891 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.01 -163.88 32.97 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.012 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 56.8 m-85 -108.96 132.54 21.13 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.657 -0.908 . . . . 0.0 109.553 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.1 Cg_endo -71.72 139.23 33.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.856 1.451 . . . . 0.0 110.068 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.4 m -120.13 169.97 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.273 -0.892 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 57.2 p30 -94.46 -167.79 1.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.856 . . . . 0.0 110.358 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -58.15 -20.84 43.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 0.0 110.516 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 -12.8 25.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.13 -0.981 . . . . 0.0 110.339 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' HB ' ' A' ' 6' ' ' VAL . . . 93.13 17.23 44.12 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 24.2 m -84.15 138.39 33.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -1.126 . . . . 0.0 110.181 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE3' ' OD1' ' A' ' 57' ' ' ASN . 10.5 mttt -58.34 146.29 35.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.401 -0.812 . . . . 0.0 110.318 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.0 tp -88.73 113.15 23.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.411 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.5 m -58.72 135.67 57.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.292 -0.88 . . . . 0.0 110.055 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 22.7 p -123.95 139.08 54.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.234 -0.916 . . . . 0.0 110.355 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.05 -10.86 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.422 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' TYR . . . -138.41 118.93 13.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -50.02 -42.04 48.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.266 -0.896 . . . . 0.0 110.75 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 26.2 p30 -56.46 -26.56 54.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.189 -0.945 . . . . 0.0 110.579 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t80 -72.64 -61.15 1.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.224 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 17.5 m -63.53 -29.88 71.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.931 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 13.8 t70 -61.36 -64.37 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.44 -0.788 . . . . 0.0 110.631 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -57.77 -39.4 77.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.173 -0.955 . . . . 0.0 110.393 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 48.7 tp60 -63.89 -63.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.127 -0.983 . . . . 0.0 110.298 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 94.2 m -42.75 -52.83 4.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.179 -0.951 . . . . 0.0 109.808 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 1.6 tptp -45.87 -51.16 13.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.383 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtm -58.56 -21.33 52.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.526 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 25' ' ' CYS . 11.0 mttt -95.27 34.1 1.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.494 -0.754 . . . . 0.0 109.989 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? 60.36 14.75 4.92 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.328 -0.857 . . . . 0.0 111.106 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -97.07 157.64 15.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.065 . . . . 0.0 109.985 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 t -116.33 -21.96 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 110.03 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 43' ' ' GLU . . . -116.73 82.67 0.33 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -112.34 122.45 5.96 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.558 ' CD2' ' CD1' ' A' ' 36' ' ' TYR . 8.5 p-80 -158.83 165.4 34.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 15' ' ' CYS . 44.5 t -85.7 105.94 16.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.167 -0.958 . . . . 0.0 110.238 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.558 ' CD1' ' CD2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -119.45 138.53 53.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.931 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 56.99 25.83 11.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 109.921 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.487 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.66 12.82 8.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.281 -0.887 . . . . 0.0 110.107 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.0 m -126.35 135.96 52.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.939 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.9 t -59.84 137.83 57.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.017 -1.052 . . . . 0.0 109.998 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -140.99 111.49 6.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.641 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 29.5 m -100.33 154.63 18.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.958 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 32' ' ' GLY . 32.6 tt0 -124.19 108.1 11.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.357 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.62 17.33 4.76 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 42' ' ' CYS . 74.0 mt -62.65 159.54 42.58 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.162 -1.199 . . . . 0.0 110.037 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 46.5 Cg_endo -72.95 164.7 34.83 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.056 1.556 . . . . 0.0 110.452 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 59.9 tt0 -71.11 -6.72 41.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.209 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.71 14.39 18.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.118 -0.989 . . . . 0.0 110.828 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -76.02 157.3 33.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.081 -1.012 . . . . 0.0 109.969 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' O ' HG22 ' A' ' 6' ' ' VAL . 14.4 tptm -97.96 109.75 22.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.895 . . . . 0.0 109.955 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 25.1 m -142.96 168.28 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.772 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -90.7 143.38 26.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.795 . . . . 0.0 110.15 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -111.48 40.81 2.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.085 -1.01 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 57' ' ' ASN . 53.6 p -153.7 129.43 10.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.0 110.238 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 6.34 19.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 110.53 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 p -144.62 75.79 1.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.044 -1.035 . . . . 0.0 110.47 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 5.7 p-10 -159.06 120.13 3.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 0.0 110.354 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.5 mt -117.15 146.41 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.979 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.6 p -110.04 145.49 36.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.116 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.525 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 pttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.359 0.599 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.497 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.2 m-20 -111.85 156.22 22.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.324 -0.86 . . . . 0.0 109.642 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.2 -162.79 36.34 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.535 -1.316 . . . . 0.0 110.059 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 12.0 m-85 -115.79 123.41 31.23 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.563 -0.963 . . . . 0.0 109.622 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.625 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.3 Cg_endo -71.24 140.61 37.59 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.997 1.525 . . . . 0.0 110.926 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 m -107.24 169.58 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.497 -0.752 . . . . 0.0 109.811 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 47.2 p30 -98.0 -179.58 4.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -0.982 . . . . 0.0 110.603 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 p -52.23 -20.38 2.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.337 -0.852 . . . . 0.0 110.293 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 10.7 tttt -80.21 -38.79 30.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.109 -0.994 . . . . 0.0 110.142 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.07 23.18 5.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' SG ' ' HG2' ' A' ' 9' ' ' LYS . 84.1 m -118.59 143.54 46.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -1.142 . . . . 0.0 110.071 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -44.84 143.13 1.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -80.42 94.43 6.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 110.525 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -43.96 139.33 2.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.86 . . . . 0.0 110.569 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.3 p -120.22 140.66 50.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 p -113.39 -6.06 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.105 -0.997 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.86 171.94 17.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.349 -0.844 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -87.52 -54.69 4.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.335 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 25.9 p-10 -47.95 -41.62 25.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.317 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 4.7 t80 -53.05 -63.83 1.02 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.991 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -53.42 -44.3 68.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.149 -0.969 . . . . 0.0 109.948 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.33 -53.72 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.879 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.5 t-20 -66.44 -54.93 18.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 109.905 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' MET . 63.6 tp60 -47.43 -59.32 3.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.933 . . . . 0.0 109.635 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 87.5 m -48.55 -51.24 28.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.85 . . . . 0.0 109.475 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.1 tttm -48.48 -47.29 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.843 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.449 ' SD ' ' OD1' ' A' ' 23' ' ' ASN . 4.3 mtp -57.41 -32.65 67.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 12.1 mmtm -88.51 14.96 8.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.374 -0.829 . . . . 0.0 109.654 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' O ' ' CD ' ' A' ' 29' ' ' LYS . 3.7 tmtm? 66.79 50.67 1.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.453 -0.779 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -110.77 177.46 4.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 110.188 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 -39.84 1.99 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 110.005 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.05 82.55 0.3 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 42' ' ' CYS . . . -100.24 118.99 6.35 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -155.72 164.74 38.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -1.113 . . . . 0.0 110.031 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.4 t -91.95 129.84 37.83 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.519 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -147.18 147.81 30.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -0.866 . . . . 0.0 110.123 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 52.25 28.58 5.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 0.0 110.248 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 1.1 ttt 69.98 4.71 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.189 -0.944 . . . . 0.0 110.476 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 m -121.96 135.66 54.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.083 -1.011 . . . . 0.0 110.421 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.2 t -65.77 140.44 58.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.256 -0.902 . . . . 0.0 109.92 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.543 ' HB2' ' CD2' ' A' ' 4' ' ' TYR . 36.6 t80 -141.48 146.15 36.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 110.698 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.609 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.5 m -126.1 151.24 47.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.41 -0.806 . . . . 0.0 109.82 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -118.32 99.25 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.234 -0.917 . . . . 0.0 110.16 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.54 24.06 1.62 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD13 HG11 ' A' ' 51' ' ' VAL . 16.9 mt -67.23 166.17 22.62 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.164 -1.198 . . . . 0.0 110.044 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.782 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -75.59 147.04 31.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.998 1.525 . . . . 0.0 110.116 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.61 -11.28 10.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.615 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 48.4 p30 -104.68 11.85 33.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 110.79 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.782 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -84.56 157.66 21.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.054 -1.029 . . . . 0.0 110.012 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.2 107.16 18.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 110.112 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.719 HG11 HD13 ' A' ' 45' ' ' LEU . 18.1 m -136.05 171.16 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.927 . . . . 0.0 110.36 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.7 t -89.85 167.02 13.17 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.372 -0.83 . . . . 0.0 109.739 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -134.14 27.79 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.148 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 p -140.05 131.52 26.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 110.268 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.54 8.49 33.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 110.387 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 t -142.88 54.71 1.39 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.004 -1.06 . . . . 0.0 110.768 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -132.39 153.03 51.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 0.0 110.053 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.19 131.01 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.166 -0.959 . . . . 0.0 110.485 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 60' ' ' GLY . 38.4 t -109.31 114.51 28.26 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.863 . . . . 0.0 110.24 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 117.962 -1.465 . . . . 0.0 109.485 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.622 ' HE3' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.311 0.577 . . . . 0.0 110.406 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.03 172.75 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.327 -0.858 . . . . 0.0 109.928 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.02 -169.75 34.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 7.4 m-85 -109.19 132.23 21.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.424 -1.045 . . . . 0.0 109.553 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 44.1 Cg_endo -71.16 138.57 33.7 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.801 1.421 . . . . 0.0 110.39 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG23 ' HG2' ' A' ' 50' ' ' LYS . 15.0 m -114.34 168.47 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 110.115 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 2.5 p30 -85.99 -178.43 6.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 p -53.92 -16.88 2.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.294 -0.879 . . . . 0.0 110.77 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 52.7 tttt -88.06 -38.75 15.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.01 -1.056 . . . . 0.0 110.315 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.78 4.5 6.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 95.7 m -88.51 136.05 33.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.162 -1.199 . . . . 0.0 110.215 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.566 ' HE3' ' CG ' ' A' ' 4' ' ' TYR . 31.4 mtpt -52.1 164.98 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.917 . . . . 0.0 110.252 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 13' ' ' LEU . 36.7 tp -100.15 114.46 27.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.458 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.8 m -65.21 144.56 57.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.712 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.421 ' C ' ' SG ' ' A' ' 35' ' ' CYS . 26.7 p -144.4 -170.13 3.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 110.684 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 35' ' ' CYS . 2.1 p -158.33 -36.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.805 . . . . 0.0 109.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -108.22 154.69 21.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.96 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -76.51 -40.72 49.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 16.4 p-10 -49.36 -34.84 16.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.875 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.4 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 1.2 t80 -58.8 -54.57 45.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.418 -0.801 . . . . 0.0 110.225 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' N ' ' A' ' 34' ' ' HIS . 50.0 m -68.19 -45.84 72.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 31.6 t70 -42.04 -48.52 4.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.869 . . . . 0.0 110.295 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -74.55 -60.57 2.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.182 -0.949 . . . . 0.0 110.163 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -48.14 -57.38 5.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.279 -0.888 . . . . 0.0 110.053 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . 86.8 m -51.57 -52.81 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.923 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -50.66 -47.44 58.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -0.818 . . . . 0.0 110.145 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -54.78 -36.22 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 2.1 mmtt -85.36 16.18 3.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 32.3 tttm 73.17 42.33 0.44 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.398 -0.814 . . . . 0.0 111.051 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -110.07 172.03 7.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.144 -0.972 . . . . 0.0 109.901 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 t -121.03 -40.72 2.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.098 -1.001 . . . . 0.0 110.319 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -105.71 85.23 0.44 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.78 115.53 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.476 ' N ' ' HB3' ' A' ' 21' ' ' CYS . 11.2 p-80 -154.68 169.25 24.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -1.118 . . . . 0.0 110.149 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' SG ' ' N ' ' A' ' 16' ' ' VAL . 45.3 t -93.55 122.86 36.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.922 . . . . 0.0 110.655 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.99 141.64 40.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.341 -0.85 . . . . 0.0 110.17 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 51.02 40.05 24.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 14' ' ' SER . 3.2 mmm 61.69 13.21 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.908 . . . . 0.0 110.336 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -131.45 149.59 52.47 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 11.7 t -79.71 136.39 36.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 110.419 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' CD1' ' CE2' ' A' ' 4' ' ' TYR . 36.3 t80 -129.41 120.55 25.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 0.0 109.898 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 7.6 m -112.81 142.28 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -113.13 113.41 25.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 110.231 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 129.34 -2.71 6.2 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.794 HD13 HG11 ' A' ' 51' ' ' VAL . 34.8 mt -53.48 158.17 3.08 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.202 -1.175 . . . . 0.0 110.122 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.837 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.1 Cg_endo -73.67 156.85 48.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.852 1.448 . . . . 0.0 110.09 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 2.4 tp10 -59.44 -15.14 15.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.996 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -113.3 24.13 12.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 110.278 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.837 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -70.24 157.52 37.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.137 -0.977 . . . . 0.0 110.233 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' HG23 ' A' ' 6' ' ' VAL . 1.4 tttp -88.35 86.33 7.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.335 -0.853 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.794 HG11 HD13 ' A' ' 45' ' ' LEU . 19.4 m -137.49 171.03 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 110.584 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.9 t -87.6 148.83 24.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.724 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.98 8.8 34.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 110.29 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 80.2 p -149.03 121.94 8.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.9 -12.79 12.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.01 56.53 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.132 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -94.88 124.44 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.322 -0.862 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' O ' HG22 ' A' ' 58' ' ' ILE . 2.2 mp -123.86 90.11 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 0.0 110.219 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 26.0 p -110.6 89.22 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 110.255 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.613 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 5.6 pttt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.374 0.607 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.451 ' CG ' ' HG2' ' A' ' 43' ' ' GLU . 1.4 m-20 -116.27 150.82 36.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.796 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.554 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . -176.77 -169.44 38.08 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.048 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 33.0 m-85 -106.32 136.98 19.29 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 0.0 109.483 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 46.9 Cg_endo -74.1 138.03 24.79 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.824 1.434 . . . . 0.0 110.619 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 6.7 m -123.05 167.6 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.417 -0.802 . . . . 0.0 110.339 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 23.6 p30 -103.94 179.5 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.366 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.1 p -54.46 -17.76 3.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 110.12 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 21.4 ttpt -79.38 -33.48 42.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.96 21.73 7.62 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 70.9 m -112.16 138.07 49.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -1.071 . . . . 0.0 110.18 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HD2' ' CB ' ' A' ' 4' ' ' TYR . 18.4 mtmm -56.77 173.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.828 . . . . 0.0 110.038 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 5' ' ' PRO . 57.0 tp -102.97 96.5 6.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 0.0 110.525 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 38' ' ' MET . 25.8 m -55.66 144.21 27.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.73 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -143.27 157.84 44.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.127 -0.983 . . . . 0.0 110.695 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 p -130.2 12.58 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.793 . . . . 0.0 109.639 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -152.01 138.33 18.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.446 -0.784 . . . . 0.0 110.086 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -70.88 -37.48 73.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.0 110.274 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.649 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 6.0 p-10 -55.17 -38.74 68.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.121 -0.987 . . . . 0.0 109.98 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' OH ' HD21 ' A' ' 13' ' ' LEU . 21.2 t80 -62.3 -42.53 99.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 110.073 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 m -73.08 -39.2 66.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.978 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 14.6 t0 -54.1 -52.58 60.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.319 -0.863 . . . . 0.0 109.83 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -70.14 -42.57 72.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.934 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 25' ' ' CYS . 54.3 tp60 -59.13 -65.15 0.71 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.766 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 94.9 m -44.68 -51.55 9.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.877 . . . . 0.0 109.899 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -55.92 7.59 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 27.7 mtp -55.1 -19.67 7.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.753 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 14.5 mmtt -95.36 19.76 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 8.7 ttmt 66.88 28.92 8.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.296 -0.877 . . . . 0.0 110.485 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -103.21 -175.13 2.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -0.926 . . . . 0.0 110.181 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.4 -40.04 0.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.866 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -102.21 82.63 0.44 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.89 120.26 6.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 3.3 p-80 -157.63 154.13 27.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 110.018 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.1 t -89.21 116.88 27.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -0.957 . . . . 0.0 110.286 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -126.83 138.51 53.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.88 . . . . 0.0 110.085 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.41 48.21 22.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 110.124 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 14' ' ' SER . 4.2 tpp 52.59 18.43 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.833 . . . . 0.0 110.315 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.2 m -133.08 141.43 48.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.982 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.491 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.3 t -75.64 140.45 42.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.554 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 43.3 t80 -137.04 130.44 31.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 34.7 m -112.51 139.44 48.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.481 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -108.63 93.96 4.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.765 . . . . 0.0 109.96 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.8 1.33 1.17 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.923 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.728 ' CD2' ' HB2' ' A' ' 30' ' ' ALA . 22.9 mt -57.06 164.63 2.26 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.639 -1.506 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.1 Cg_endo -71.1 160.98 47.49 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.924 1.486 . . . . 0.0 110.361 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 4.8 tp10 -58.44 -18.44 28.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 110.861 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -122.34 30.08 6.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.051 -1.031 . . . . 0.0 110.605 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.838 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -62.75 156.06 24.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.038 -1.039 . . . . 0.0 109.883 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.3 tttp -83.8 77.94 9.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.832 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 45' ' ' LEU . 6.7 m -128.21 169.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.916 . . . . 0.0 110.52 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 12' ' ' LYS . 6.2 t -90.14 133.24 35.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.413 -0.805 . . . . 0.0 110.122 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -107.97 18.76 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.747 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.5 p -121.2 99.45 6.5 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.491 -0.756 . . . . 0.0 110.067 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.96 -9.81 17.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 110.343 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 56' ' ' THR . 47.5 m -122.6 73.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.454 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -149.34 138.31 21.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.259 -0.901 . . . . 0.0 110.247 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.68 HG23 ' O ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -139.08 117.26 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.227 -0.921 . . . . 0.0 110.472 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.443 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 24.6 p -99.2 100.1 11.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -0.914 . . . . 0.0 110.171 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.025 -1.431 . . . . 0.0 109.63 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 41.7 pttt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.166 0.508 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' CYS . 10.4 m-20 -102.82 137.39 41.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 109.795 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CE1' ' A' ' 41' ' ' TYR . . . 179.87 -170.09 41.18 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.347 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 97.5 m-85 -102.0 124.85 38.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.415 -1.05 . . . . 0.0 110.16 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 51' ' ' VAL . 53.0 Cg_endo -80.79 141.68 13.66 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.856 1.45 . . . . 0.0 110.494 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 50' ' ' LYS . 29.3 m -115.52 173.66 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 109.999 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 17.9 p30 -95.95 173.0 7.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.21 -0.931 . . . . 0.0 110.276 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.4 p -44.4 -25.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.523 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.58 -39.96 21.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.37 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.04 4.38 8.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 56.9 m -83.28 137.69 33.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -1.147 . . . . 0.0 110.312 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 52' ' ' SER . 18.6 mttt -56.3 145.63 26.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.857 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 24' ' ' GLN . 33.7 tp -80.2 114.26 18.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.27 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 45.7 m -65.26 116.15 6.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.766 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 31.3 p -90.61 136.1 33.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.016 . . . . 0.0 110.469 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -111.17 -21.22 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.492 -0.755 . . . . 0.0 109.859 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.63 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -156.4 143.63 19.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.021 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -47.96 -47.7 32.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.63 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -53.87 -44.21 70.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 0.0 110.307 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' ALA . 40.6 t80 -52.71 -36.82 58.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.191 -0.943 . . . . 0.0 110.154 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' O ' ' C ' ' A' ' 22' ' ' ASP . 9.8 m -83.98 -47.52 10.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.9 . . . . 0.0 110.265 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 21' ' ' CYS . 43.2 t0 -44.3 -36.07 2.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.011 . . . . 0.0 109.627 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.453 ' O ' ' HB3' ' A' ' 26' ' ' LYS . 3.2 t30 -82.96 -61.42 1.87 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.335 -0.853 . . . . 0.0 109.629 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' HG2' ' CD2' ' A' ' 13' ' ' LEU . 34.8 tp60 -44.65 -51.44 9.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.029 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.05 -50.23 74.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.559 -0.713 . . . . 0.0 109.169 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 23' ' ' ASN . 16.0 tttt -49.51 -46.79 48.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.401 -0.812 . . . . 0.0 109.564 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.6 mtp -57.48 -32.53 67.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.436 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 1.3 mmmp? -88.63 27.17 1.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.406 -0.808 . . . . 0.0 110.309 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp 60.13 44.28 13.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -0.968 . . . . 0.0 110.819 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -112.84 177.48 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.243 -0.911 . . . . 0.0 109.612 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 t -128.5 -39.39 1.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 110.617 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.76 80.16 0.27 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.15 116.03 5.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -148.38 170.7 17.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.0 110.114 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 16.1 t -97.92 139.47 33.72 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.95 . . . . 0.0 110.449 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -157.48 124.31 5.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.367 -0.833 . . . . 0.0 110.086 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 67.48 36.31 3.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 7.2 mtt 60.83 10.26 2.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -0.789 . . . . 0.0 110.307 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 m -124.63 142.75 51.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.9 t -74.92 143.68 43.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.579 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 35.3 t80 -136.03 132.79 36.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.347 -0.845 . . . . 0.0 109.886 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.515 ' HB2' ' CG ' ' A' ' 45' ' ' LEU . 12.1 m -117.92 144.97 45.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 110.267 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 18.3 tt0 -108.99 92.99 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.68 30.87 0.86 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 42' ' ' CYS . 58.0 mt -68.48 168.27 15.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.159 -1.201 . . . . 0.0 110.159 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.863 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.1 Cg_endo -74.86 134.77 18.48 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.857 1.451 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -48.23 -22.57 0.68 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.268 -0.895 . . . . 0.0 110.731 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 3.8 p-10 -105.77 19.55 20.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 0.0 110.552 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.863 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -72.1 156.37 39.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 110.323 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.945 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -94.75 99.98 11.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.414 -0.804 . . . . 0.0 109.813 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 5' ' ' PRO . 22.6 m -129.78 169.42 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 110.637 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.436 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 2.1 t -90.3 150.36 21.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.416 -0.802 . . . . 0.0 109.994 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -105.45 29.0 6.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.961 . . . . 0.0 110.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 98.3 p -156.5 163.25 39.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.289 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.08 -5.37 56.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.398 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -172.9 3.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.165 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 3.0 p-10 -103.27 124.28 48.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.099 -1.0 . . . . 0.0 110.5 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' O ' HG12 ' A' ' 58' ' ' ILE . 4.2 tt -129.64 84.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.64 -167.38 1.84 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.27 -0.894 . . . . 0.0 110.377 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 118.009 -1.44 . . . . 0.0 109.554 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 38.0 pttt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.352 0.596 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -112.85 163.34 14.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.308 -0.87 . . . . 0.0 109.858 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.89 175.97 36.82 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.47 -1.347 . . . . 0.0 110.243 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 41' ' ' TYR . 46.8 m-85 -102.41 132.0 21.88 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.405 -1.056 . . . . 0.0 109.516 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -69.8 137.65 35.84 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.695 1.366 . . . . 0.0 110.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -107.72 170.71 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.358 -0.839 . . . . 0.0 110.297 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -104.18 -168.64 1.52 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 110.352 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.6 p -60.12 -16.97 36.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.307 -0.871 . . . . 0.0 110.838 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -90.84 -28.44 18.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.531 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.24 7.48 26.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.11 141.87 30.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 110.194 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 159.34 0.19 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.903 . . . . 0.0 110.272 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 ' OH ' ' A' ' 20' ' ' TYR . 8.0 tp -91.99 143.55 26.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.022 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.0 m -85.05 155.8 21.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.942 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.7 p -147.93 150.79 34.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 110.326 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.02 -4.97 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 110.031 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.591 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -147.65 154.18 40.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -74.14 -42.0 60.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.189 -0.945 . . . . 0.0 110.325 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.591 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 4.9 p-10 -51.94 -45.6 64.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.94 . . . . 0.0 110.427 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' OH ' HD21 ' A' ' 13' ' ' LEU . 13.8 t80 -44.81 -44.32 9.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.191 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 56.1 m -75.96 -41.5 51.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.945 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -45.9 -52.89 10.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -0.865 . . . . 0.0 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -74.26 -38.29 63.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 34.8 tp60 -63.69 -54.14 40.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.162 -0.961 . . . . 0.0 109.91 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 90.8 m -55.25 -53.27 58.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 0.0 109.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.37 -49.1 25.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.738 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -36.06 62.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 0.0 109.996 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 29' ' ' LYS . 18.1 mttm -88.37 20.76 3.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 110.543 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 70.38 43.02 0.85 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.27 -0.894 . . . . 0.0 110.998 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -120.11 176.22 5.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.037 -1.039 . . . . 0.0 109.659 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.28 -39.56 1.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 110.607 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -100.84 86.32 0.62 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -107.81 122.15 6.66 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' NE2' ' HB3' ' A' ' 41' ' ' TYR . 4.0 p-80 -154.52 174.1 15.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.1 t -100.39 118.72 37.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 0.0 109.776 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -135.1 134.05 39.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 110.812 -179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.38 37.52 23.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.819 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.489 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.5 tpt 68.69 4.59 4.45 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.22 -0.925 . . . . 0.0 110.885 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 13' ' ' LEU . 1.6 m -126.36 158.8 34.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.04 -1.038 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 t -84.72 155.48 21.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.932 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' CE1' ' CE1' ' A' ' 4' ' ' TYR . 26.6 t80 -149.51 137.59 20.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 34.5 m -122.11 146.45 47.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.192 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 24.8 tt0 -117.22 103.43 10.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.361 -0.837 . . . . 0.0 110.161 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 45' ' ' LEU . . . 126.93 -1.13 7.27 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD13 HG11 ' A' ' 51' ' ' VAL . 16.0 mt -43.26 169.88 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.404 -1.056 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 44.0 Cg_endo -70.69 151.62 63.93 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.557 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -54.9 -18.69 5.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 0.0 110.624 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -121.9 33.17 5.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.038 -1.039 . . . . 0.0 110.699 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.642 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.86 157.2 25.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.038 -1.039 . . . . 0.0 109.742 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.735 ' O ' HG22 ' A' ' 6' ' ' VAL . 7.7 tptt -95.07 76.91 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.659 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 5' ' ' PRO . 23.5 m -123.82 173.62 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 110.853 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.5 t -77.46 148.07 35.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.465 -0.772 . . . . 0.0 109.954 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 53' ' ' ASP . 49.1 p30 -112.38 15.09 20.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.912 . . . . 0.0 110.268 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.502 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 2.4 p -128.06 112.91 15.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.461 ' C ' HG23 ' A' ' 56' ' ' THR . . . -90.02 18.09 6.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 110.249 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 55' ' ' ALA . 61.7 p -150.08 55.54 0.94 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.991 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 19.5 p-10 -160.12 130.2 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 110.259 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 58' ' ' ILE . 1.5 tp -101.29 114.63 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 0.0 109.819 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 29.4 p -81.29 143.37 32.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.977 -1.077 . . . . 0.0 110.445 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 45' ' ' LEU . 2.2 pttm . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.302 0.573 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 4.2 m-20 -103.56 157.12 17.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.94 41.11 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.214 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 34.3 m-85 -103.6 123.9 39.81 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.424 -1.045 . . . . 0.0 110.151 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.55 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.1 Cg_endo -73.88 141.1 29.75 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.862 1.454 . . . . 0.0 110.551 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 50' ' ' LYS . 31.8 m -116.31 176.28 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.875 . . . . 0.0 110.322 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -101.44 -179.16 3.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.402 -0.811 . . . . 0.0 109.883 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 64.4 p -51.18 -21.59 2.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -43.03 19.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 110.058 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.94 2.34 8.62 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.4 m -83.46 145.19 29.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -1.174 . . . . 0.0 110.232 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 54' ' ' SER . 4.6 mttp -55.3 153.32 7.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 110.029 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.575 HD11 ' OH ' ' A' ' 20' ' ' TYR . 34.2 tp -79.06 88.37 4.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.255 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' MET . 1.1 m -37.37 135.97 0.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.626 -0.671 . . . . 0.0 110.818 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 40' ' ' CYS . 17.2 p -124.69 136.45 53.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 110.146 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.89 0.54 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.123 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -160.14 168.1 26.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.387 -0.821 . . . . 0.0 110.15 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -86.75 -35.28 19.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.069 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 11.3 p-10 -58.44 -43.42 88.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.575 ' OH ' HD11 ' A' ' 13' ' ' LEU . 12.8 t80 -61.71 -48.07 82.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.3 m -68.05 -39.31 83.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -54.57 -56.24 21.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 110.187 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' O ' ' HG3' ' A' ' 27' ' ' MET . 4.9 t-20 -64.76 -45.73 85.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 110.299 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' NE2' ' HA ' ' A' ' 24' ' ' GLN . 7.4 tp-100 -56.93 -68.04 0.26 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.212 -0.93 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' C ' ' HB3' ' A' ' 30' ' ' ALA . 71.6 m -44.22 -54.36 5.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 0.0 109.627 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 3.6 ttmt -45.63 -52.06 11.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.431 -0.793 . . . . 0.0 109.799 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.41 ' HG3' ' O ' ' A' ' 23' ' ' ASN . 1.7 mtt -56.84 -23.57 45.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.319 -0.863 . . . . 0.0 110.236 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 5' ' ' PRO . 25.7 mtpp -99.02 39.49 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.617 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 9.6 tttt 58.74 19.36 6.79 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.406 -0.809 . . . . 0.0 111.068 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -101.3 158.09 16.31 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.024 -1.047 . . . . 0.0 110.048 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -116.76 -34.6 4.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.292 -0.88 . . . . 0.0 110.155 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -97.72 83.34 0.7 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.58 122.97 7.2 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' A' ' 36' ' ' TYR . 13.5 p-80 -159.55 169.17 24.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -1.051 . . . . 0.0 109.681 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 13.8 t -98.05 136.51 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.042 -1.036 . . . . 0.0 110.695 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -154.37 134.31 13.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.362 -0.836 . . . . 0.0 110.107 179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.26 45.23 20.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 14' ' ' SER . 1.4 mmt 53.87 16.31 1.03 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.274 -0.891 . . . . 0.0 110.584 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 m -133.1 137.61 46.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.005 -1.059 . . . . 0.0 110.071 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 15' ' ' CYS . 6.2 t -72.67 141.45 48.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 110.471 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.0 t80 -130.6 140.09 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 0.0 110.113 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.665 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.1 m -129.07 143.67 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.221 -0.925 . . . . 0.0 110.157 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 53.6 tt0 -112.53 102.92 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.366 -0.834 . . . . 0.0 109.996 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.31 11.54 3.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 42' ' ' CYS . 80.3 mt -59.97 164.2 6.5 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.104 -1.233 . . . . 0.0 110.469 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.759 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.7 Cg_endo -73.63 139.8 28.65 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.978 1.515 . . . . 0.0 109.855 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 47' ' ' GLU . 3.0 tm-20 -55.01 -27.3 43.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.022 . . . . 0.0 110.835 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -88.39 4.64 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.974 . . . . 0.0 111.234 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.759 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -68.86 152.33 45.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.737 -1.227 . . . . 0.0 109.804 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.76 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.8 tmtp? -95.27 101.9 13.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.502 -0.748 . . . . 0.0 109.868 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 5' ' ' PRO . 16.7 m -127.02 168.73 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 110.738 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.0 t -89.3 141.52 28.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.471 -0.768 . . . . 0.0 109.896 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 53' ' ' ASP . 16.5 p30 -99.1 32.14 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.305 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.504 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 5.0 p -154.56 148.17 25.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.919 . . . . 0.0 110.018 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.12 -18.38 60.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 109.991 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -123.85 116.38 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.319 -0.863 . . . . 0.0 109.898 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 59' ' ' CYS . 8.6 p30 -102.07 170.86 7.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.937 . . . . 0.0 110.363 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.533 ' O ' HG22 ' A' ' 58' ' ' ILE . 3.3 mp -109.87 51.69 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 110.276 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' OD1' ' A' ' 57' ' ' ASN . 49.3 t -84.45 127.53 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 110.164 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.761 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 20.0 pttt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.273 0.559 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -124.34 151.23 44.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.895 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.17 -167.74 40.27 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 61.4 m-85 -101.92 132.59 21.44 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.077 . . . . 0.0 109.768 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -73.89 140.66 29.09 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.872 1.459 . . . . 0.0 110.143 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.985 HG22 ' O ' ' A' ' 50' ' ' LYS . 28.7 m -123.34 170.27 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 110.311 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -95.47 179.02 5.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.484 -0.76 . . . . 0.0 109.991 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.1 p -52.26 -19.31 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.08 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -79.63 -30.88 41.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.963 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.72 33.99 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 2.0 m -93.92 155.0 17.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -1.128 . . . . 0.0 110.17 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -66.87 149.62 50.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.386 -0.821 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 14' ' ' SER . 8.0 tp -89.09 98.61 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.875 . . . . 0.0 110.247 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 13' ' ' LEU . 2.3 m -43.57 140.1 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.892 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 39' ' ' SER . 15.1 p -129.39 136.91 50.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 110.604 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -123.68 -7.07 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.83 . . . . 0.0 109.78 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.65 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -150.16 153.29 36.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 110.01 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.2 -43.28 67.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.65 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 14.5 p-10 -49.52 -45.81 47.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -55.06 -45.71 75.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.2 m -74.46 -28.57 61.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.875 . . . . 0.0 110.334 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -57.67 -49.07 77.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.172 -0.955 . . . . 0.0 110.432 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -75.36 -49.92 17.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.908 . . . . 0.0 110.301 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -53.54 -52.7 58.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.981 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 48.9 m -56.65 -44.88 81.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.219 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -56.24 -44.94 80.1 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.435 -0.79 . . . . 0.0 109.266 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.0 mtp -59.49 -29.46 67.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.812 . . . . 0.0 109.438 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -89.18 12.72 15.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -0.799 . . . . 0.0 109.668 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 42.4 tttm 64.64 55.22 1.32 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 110.292 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.575 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -124.04 163.45 21.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.533 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 p -113.29 -33.27 6.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.2 77.92 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.491 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.96 118.74 6.23 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.0 p-80 -151.74 171.87 17.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.27 -1.135 . . . . 0.0 110.239 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.6 t -101.71 133.34 46.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 6.4 t80 -158.33 148.22 19.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.897 . . . . 0.0 110.375 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 56.61 33.52 22.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.689 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.05 14.31 9.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.978 . . . . 0.0 110.587 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 15' ' ' CYS . 56.0 m -140.53 155.96 46.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 0.0 110.393 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 6.3 t -79.06 159.4 27.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 110.276 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -154.01 125.04 7.29 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.721 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.575 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 30.9 m -113.58 145.83 40.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 110.426 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.62 119.97 39.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.345 -0.847 . . . . 0.0 109.914 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.87 5.79 26.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 52.0 mt -48.59 167.55 0.2 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -1.111 . . . . 0.0 110.287 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 42.4 Cg_endo -70.53 156.37 61.49 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.971 1.511 . . . . 0.0 110.57 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 0.8 OUTLIER -57.48 -37.52 73.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.931 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -102.61 24.65 10.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.761 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -59.04 157.02 10.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.23 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.985 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.5 tptt -98.27 94.52 6.82 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.357 -0.84 . . . . 0.0 109.662 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 45' ' ' LEU . 22.6 m -128.42 169.23 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -81.63 156.02 25.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.345 -0.847 . . . . 0.0 109.719 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -108.09 6.48 26.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 110.201 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -147.1 147.97 31.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 110.364 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.27 -17.51 63.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 109.977 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.78 177.89 6.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.797 . . . . 0.0 110.173 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 7.9 p-10 -82.46 91.7 6.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.167 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 58' ' ' ILE . 4.9 tp -97.42 60.77 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.167 -0.958 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 74.05 5.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.855 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.515 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.17 0.51 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 7.9 m-20 -103.81 140.7 37.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.07 -168.47 40.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.278 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 36.7 m-85 -104.99 134.93 19.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.564 -0.962 . . . . 0.0 109.964 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' ' O ' ' A' ' 40' ' ' CYS . 47.5 Cg_endo -75.0 138.4 22.98 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.891 1.469 . . . . 0.0 110.423 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 50' ' ' LYS . 21.8 m -123.85 175.94 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.817 . . . . 0.0 110.354 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 31.4 p30 -101.47 -171.16 1.94 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.592 -0.692 . . . . 0.0 110.23 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -61.01 -11.97 9.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.378 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -98.29 -21.93 16.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.94 . . . . 0.0 110.662 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.44 2.72 44.11 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 53.8 m -79.92 141.25 36.24 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -1.082 . . . . 0.0 109.953 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -67.95 144.66 55.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 109.805 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.591 HD21 ' OH ' ' A' ' 20' ' ' TYR . 23.8 tp -79.66 106.58 11.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -0.983 . . . . 0.0 110.211 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -48.08 126.86 11.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 110.159 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 27.8 p -109.71 146.96 34.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -129.56 -25.21 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.639 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -129.58 127.51 40.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.123 -0.986 . . . . 0.0 110.205 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 29.3 m-20 -57.24 -25.36 59.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 110.157 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.639 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 5.7 p-10 -72.61 -30.52 64.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.591 ' OH ' HD21 ' A' ' 13' ' ' LEU . 26.1 t80 -63.21 -48.58 77.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -71.92 -41.75 67.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.828 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.4 t0 -49.23 -39.53 30.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -76.75 -56.44 4.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.0 109.763 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -52.51 -55.84 19.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.784 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 82.1 m -51.64 -55.35 19.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.555 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -48.37 -42.08 30.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -66.92 -26.27 66.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 110.005 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 5.1 mmtt -89.15 23.4 2.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 0.0 110.007 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 66.31 19.33 11.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -88.39 166.42 14.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.93 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 43' ' ' GLU . 47.6 p -117.52 -26.65 6.57 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.885 . . . . 0.0 110.184 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -121.52 87.7 0.41 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -105.58 115.75 4.97 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -151.43 174.53 13.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.289 -1.124 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 6.1 t -105.1 130.08 53.36 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.935 . . . . 0.0 110.234 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 2.2 t80 -144.81 139.88 28.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.057 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 57.19 38.66 28.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 110.063 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 59.7 17.36 6.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.403 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 69.8 m -131.44 138.45 49.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.236 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 16.7 t -69.43 157.71 36.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.181 -0.949 . . . . 0.0 109.987 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' CD2' ' CE1' ' A' ' 4' ' ' TYR . 39.0 t80 -158.43 140.03 13.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 110.286 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.485 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 12.3 m -128.27 143.77 51.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.956 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.9 tm-20 -103.76 101.21 11.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 119.36 21.72 3.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.724 HD13 HG11 ' A' ' 51' ' ' VAL . 5.3 mt -54.6 166.93 0.65 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.908 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.66 145.25 36.77 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.941 1.495 . . . . 0.0 110.598 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 47' ' ' GLU . 1.3 tp10 -58.8 -17.51 24.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 110.33 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.491 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 46.3 p30 -102.48 18.38 21.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.127 -0.983 . . . . 0.0 110.727 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.908 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -86.51 157.65 19.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 110.204 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -103.74 105.73 16.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.819 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG11 HD13 ' A' ' 45' ' ' LEU . 28.9 m -134.1 168.34 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 110.628 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -87.79 127.12 35.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.411 -0.806 . . . . 0.0 109.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.15 25.66 2.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 110.393 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.7 p -155.93 145.0 20.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.78 14.91 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.148 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.1 p -135.78 75.82 1.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.288 -0.882 . . . . 0.0 110.488 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -118.82 174.81 6.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.051 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.4 mt -127.73 110.63 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 110.777 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 60' ' ' GLY . 11.0 t -79.66 107.35 12.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 110.036 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 59' ' ' CYS . . . . . . . . 0 N--CA 1.491 2.345 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 51' ' ' VAL . 13.3 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.402 0.62 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 1.2 m-20 -113.01 152.76 29.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.413 -0.804 . . . . 0.0 109.73 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.95 -166.73 37.66 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.131 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 96.7 m-85 -108.96 126.95 28.22 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.555 -0.967 . . . . 0.0 110.115 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.1 Cg_endo -72.98 140.27 31.3 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.815 1.429 . . . . 0.0 110.295 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 50' ' ' LYS . 10.4 m -105.69 -178.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.388 -0.82 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 11' ' ' CYS . 39.5 p-10 -109.96 -164.78 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.703 -0.623 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.0 p -67.78 -4.62 13.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.229 -0.92 . . . . 0.0 110.558 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.16 -13.78 12.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.329 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 103.19 0.63 47.76 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 34.2 m -79.78 152.6 29.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -1.191 . . . . 0.0 110.057 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -78.49 145.1 35.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.479 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.2 tp -79.98 108.94 13.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -0.897 . . . . 0.0 110.114 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' MET . 72.9 m -58.61 161.81 4.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 39' ' ' SER . 26.3 p -146.84 143.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 110.474 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 p -118.68 -25.21 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.692 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -121.81 171.42 8.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.394 -0.816 . . . . 0.0 110.129 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -90.38 -37.04 14.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.0 110.567 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 11.8 p30 -65.49 -45.19 84.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.523 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.4 t80 -45.1 -43.42 9.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.06 -1.025 . . . . 0.0 109.618 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.1 m -76.36 -45.35 32.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.816 . . . . 0.0 109.924 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 8.6 t70 -46.6 -35.19 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.87 . . . . 0.0 109.647 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -78.03 -62.89 1.53 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.766 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 6.5 tp-100 -47.04 -57.73 4.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.433 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' LYS . 84.0 m -52.06 -54.79 25.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 4.5 ttmt -45.09 -60.23 2.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.1 mtp -48.98 -26.48 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.712 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 46' ' ' PRO . 13.7 mttm -92.97 43.18 1.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.36 -0.838 . . . . 0.0 110.053 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 28' ' ' LYS . 8.6 tttt 42.38 30.64 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.343 -0.848 . . . . 0.0 110.64 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -89.54 161.52 16.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.069 -1.02 . . . . 0.0 109.961 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 p -111.31 -40.12 4.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 110.254 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -114.53 88.28 0.47 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.62 121.26 6.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -157.48 171.27 20.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -1.11 . . . . 0.0 109.719 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.0 t -101.97 141.54 34.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.0 110.697 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.84 151.58 23.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.413 -0.804 . . . . 0.0 109.999 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 50.11 34.96 9.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 61.63 12.41 4.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.226 -0.921 . . . . 0.0 110.411 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 18.1 m -129.21 135.46 48.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.916 . . . . 0.0 110.46 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 7.2 t -62.44 139.84 58.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 110.179 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 73.7 t80 -134.28 151.41 51.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 110.255 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 5.1 m -138.45 138.68 38.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.22 -0.925 . . . . 0.0 109.806 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 10.4 tt0 -107.64 96.95 6.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 133.83 2.26 3.54 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.161 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.627 HD13 HG11 ' A' ' 51' ' ' VAL . 82.9 mt -42.41 162.09 0.16 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.106 -1.232 . . . . 0.0 109.923 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.685 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.5 Cg_endo -72.84 132.16 18.09 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.884 1.465 . . . . 0.0 109.904 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.4 -22.43 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.22 -0.925 . . . . 0.0 110.642 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -95.03 14.22 22.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.096 -1.002 . . . . 0.0 110.661 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.685 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -81.13 158.5 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 0.0 109.945 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 6' ' ' VAL . 46.1 tttp -104.46 97.6 7.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.627 HG11 HD13 ' A' ' 45' ' ' LEU . 19.8 m -123.03 167.87 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 110.291 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.9 t -90.45 133.42 35.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 17.0 p-10 -87.8 21.56 2.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.282 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 p -133.54 122.42 23.55 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 110.232 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -15.6 50.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.138 -0.977 . . . . 0.0 110.506 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 56' ' ' THR . 2.5 t -144.81 112.0 6.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 110.242 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 21.7 p-10 -159.36 154.74 25.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.184 -0.948 . . . . 0.0 110.247 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt -97.22 144.24 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.358 -0.839 . . . . 0.0 110.25 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 44.1 t -108.82 119.12 38.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.335 -0.853 . . . . 0.0 110.163 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.613 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 46' ' ' PRO . 40.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.243 0.544 . . . . 0.0 110.284 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 6.6 m-20 -124.73 156.1 38.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.382 -0.824 . . . . 0.0 109.67 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.75 -165.23 37.4 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.29 -1.433 . . . . 0.0 110.39 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 57.3 m-85 -105.08 132.41 20.9 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.602 -0.94 . . . . 0.0 110.003 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' HA ' HG12 ' A' ' 51' ' ' VAL . 46.3 Cg_endo -74.56 147.69 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.966 1.508 . . . . 0.0 110.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 50' ' ' LYS . 27.7 m -106.45 174.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.262 -0.899 . . . . 0.0 110.357 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 52.5 p-10 -111.13 -170.47 1.64 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.815 . . . . 0.0 110.452 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.0 p -60.46 -18.77 53.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.306 -0.871 . . . . 0.0 110.679 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -94.93 -24.52 16.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.135 -0.978 . . . . 0.0 110.547 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 113.14 2.29 24.94 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 59' ' ' CYS . 27.5 m -93.41 145.72 24.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 110.084 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 2.9 mtpt -61.04 156.29 18.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 110.295 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.3 tp -85.03 97.46 9.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 38' ' ' MET . 13.3 m -62.3 128.83 37.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.832 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 8.2 p -121.83 -174.61 2.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 110.635 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 17' ' ' ALA . 3.7 p -143.67 -36.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 109.868 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -103.72 166.78 10.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.951 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' ASN . 68.7 m-20 -90.06 -53.32 4.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 18' ' ' ASN . 11.5 p30 -43.17 -29.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 110.268 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -67.05 -49.45 65.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 109.986 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.5 m -69.25 -39.69 78.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -51.98 -55.09 22.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.334 -0.854 . . . . 0.0 110.117 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' GLN . 8.3 t30 -68.61 -60.37 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.082 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -43.36 -56.89 3.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 110.133 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 76.7 m -48.64 -53.9 16.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.906 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -45.91 -55.43 6.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.171 -0.956 . . . . 0.0 109.419 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 33.1 mtm -50.33 -27.07 5.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.306 -0.872 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 25' ' ' CYS . 4.8 mmpp? -94.05 34.85 1.2 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.967 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.9 tptt 50.82 39.38 22.14 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.383 -0.823 . . . . 0.0 110.944 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -107.27 171.18 7.52 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.025 -1.047 . . . . 0.0 109.986 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.09 -23.79 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.155 -0.965 . . . . 0.0 110.406 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -126.96 87.72 0.34 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.5 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -101.81 123.44 7.9 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.166 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.45 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 3.6 p-80 -156.57 153.77 29.17 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.249 -1.148 . . . . 0.0 109.897 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 33.7 t -90.05 139.95 30.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.169 -0.957 . . . . 0.0 110.59 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.517 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -156.94 140.07 15.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.026 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 59.79 28.01 17.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.928 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER 72.79 0.38 3.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.428 -0.795 . . . . 0.0 110.625 179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 1.4 m -118.16 138.34 52.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.059 -1.026 . . . . 0.0 110.237 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 15' ' ' CYS . 8.5 t -69.33 154.08 42.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.171 -0.956 . . . . 0.0 110.019 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HD1' ' CE2' ' A' ' 4' ' ' TYR . 72.5 t80 -147.3 133.94 19.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 0.0 110.552 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.664 ' HB2' HD21 ' A' ' 45' ' ' LEU . 22.1 m -121.83 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.887 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.426 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 4.5 tp10 -108.55 108.78 19.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.39 -0.819 . . . . 0.0 110.054 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 121.88 13.0 5.18 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 42' ' ' CYS . 37.9 mt -53.58 164.19 0.9 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -1.145 . . . . 0.0 110.261 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.695 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 44.8 Cg_endo -73.87 156.83 48.03 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.989 1.521 . . . . 0.0 110.628 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 33.2 tt0 -63.39 -16.69 61.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 110.389 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 6.0 p-10 -112.64 21.82 15.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.088 -1.008 . . . . 0.0 111.042 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.695 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -74.48 157.66 35.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 0.0 109.851 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 6' ' ' VAL . 2.7 tptm -98.02 107.02 19.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.667 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 5' ' ' PRO . 18.6 m -140.69 169.73 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.676 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -84.56 175.51 9.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.344 -0.847 . . . . 0.0 109.568 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -125.7 16.74 8.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.748 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.1 p -150.33 148.76 29.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.054 -1.029 . . . . 0.0 110.167 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.3 -24.89 67.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.881 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.65 141.1 50.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.451 ' N ' ' ND2' ' A' ' 57' ' ' ASN . 1.2 p30 -145.83 179.84 7.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 110.229 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.659 ' O ' HG22 ' A' ' 58' ' ' ILE . 11.4 mt -114.86 56.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.988 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' SG ' ' N ' ' A' ' 11' ' ' CYS . 10.4 t -116.52 139.57 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.967 . . . . 0.0 110.431 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' SG ' ' A' ' 11' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.274 0 CA-C-O 118.078 -1.401 . . . . 0.0 109.65 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 18.0 pttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.212 0.529 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' HB3' ' OH ' ' A' ' 41' ' ' TYR . 4.9 m-20 -111.95 140.65 46.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.729 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 41' ' ' TYR . . . -175.96 -170.18 38.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.547 ' CE1' ' HB2' ' A' ' 41' ' ' TYR . 39.2 m-85 -115.15 124.41 30.27 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.534 -0.98 . . . . 0.0 109.47 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.4 Cg_endo -70.83 137.69 32.85 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.808 1.425 . . . . 0.0 110.232 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 19.1 m -101.91 168.32 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.441 -0.787 . . . . 0.0 109.897 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -87.28 179.58 6.59 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.054 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 p -56.7 -16.1 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -82.95 -40.08 20.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 110.439 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -11.02 6.62 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 39.5 m -84.54 169.19 14.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.183 -1.187 . . . . 0.0 110.25 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -77.44 149.04 35.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 0.0 110.077 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 20' ' ' TYR . 13.0 tp -85.23 107.9 17.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.135 -0.978 . . . . 0.0 110.59 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' MET . 4.6 m -56.04 149.03 16.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.56 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.0 p -137.65 150.12 47.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.159 -0.963 . . . . 0.0 110.675 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 17' ' ' ALA . 9.0 p -123.89 -36.11 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.845 ' HB1' ' OD1' ' A' ' 19' ' ' ASN . . . -115.19 133.96 55.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 110.101 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -59.81 -44.14 94.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 110.307 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.845 ' OD1' ' HB1' ' A' ' 17' ' ' ALA . 13.8 p-10 -46.38 -43.42 16.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.2 -0.938 . . . . 0.0 109.94 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -53.92 -46.87 71.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.901 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 15.3 m -77.16 -34.52 56.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.066 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.83 -51.77 15.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' GLN . 11.7 t-20 -73.57 -47.84 37.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.665 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' ASN . 37.3 tp60 -42.55 -63.17 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.451 -0.781 . . . . 0.0 109.716 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' CA ' ' A' ' 33' ' ' GLY . 65.7 m -54.62 -56.04 23.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.9 OUTLIER -41.28 -51.97 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.473 -0.767 . . . . 0.0 109.633 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.4 mtm -54.68 -35.08 63.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.45 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -87.7 33.75 0.71 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.414 -0.803 . . . . 0.0 109.781 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER 43.27 43.87 4.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 110.454 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -96.39 179.23 5.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.424 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.64 -45.27 2.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.027 -1.046 . . . . 0.0 110.208 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -111.28 87.2 0.46 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -105.17 122.14 7.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.415 ' CE1' ' HB2' ' A' ' 36' ' ' TYR . 6.7 p80 -160.25 170.58 20.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -1.127 . . . . 0.0 109.814 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.4 t -95.74 115.61 27.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.151 -0.968 . . . . 0.0 110.099 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -138.74 160.02 40.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 110.478 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.07 37.5 8.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 110.479 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.8 OUTLIER 57.21 17.84 3.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.415 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.5 m -143.65 155.93 44.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 110.237 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 1.8 t -76.09 139.34 41.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.084 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.547 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 59.7 t80 -143.45 125.77 15.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.23 -0.919 . . . . 0.0 110.0 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 11.4 m -113.69 148.74 35.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.196 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 1.7 tp10 -112.59 94.59 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.499 -0.751 . . . . 0.0 110.178 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 45' ' ' LEU . . . 138.13 -4.51 3.19 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 51' ' ' VAL . 31.5 mt -41.5 160.23 0.16 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.288 -1.125 . . . . 0.0 110.312 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.548 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 48.2 Cg_endo -75.03 160.49 40.01 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.973 1.512 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' C ' ' OE1' ' A' ' 47' ' ' GLU . 4.3 tm-20 -61.6 -27.25 68.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.918 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -95.29 17.25 14.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 0.0 110.713 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -63.75 154.89 31.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.005 -1.059 . . . . 0.0 109.914 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -98.18 82.67 2.97 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.777 . . . . 0.0 109.895 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 5' ' ' PRO . 25.4 m -132.75 170.07 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 110.26 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 t -88.36 155.96 19.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.875 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -119.37 45.87 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.099 -1.001 . . . . 0.0 110.322 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.493 ' OG ' ' ND2' ' A' ' 57' ' ' ASN . 89.0 p -156.43 125.15 5.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.036 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.64 9.74 25.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.532 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 p -138.33 69.91 1.38 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.12 -0.988 . . . . 0.0 110.337 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.493 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 38.2 p-10 -159.24 156.35 28.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.11 -0.994 . . . . 0.0 110.355 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -120.95 149.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.343 -0.848 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.15 162.95 21.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 110.188 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.564 -179.9 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 12.5 pttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.205 0.526 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HA ' ' A' ' 43' ' ' GLU . 4.3 m-20 -108.29 143.31 37.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.253 -0.904 . . . . 0.0 109.467 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.73 -174.09 39.05 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.362 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 85.4 m-85 -104.97 119.3 53.74 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.535 -0.979 . . . . 0.0 109.949 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.7 140.33 42.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.818 1.43 . . . . 0.0 110.389 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 16.4 m -117.32 172.9 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.378 -0.826 . . . . 0.0 110.17 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 7.0 p30 -90.15 -161.54 0.8 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 p -67.67 -6.35 20.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.297 -0.877 . . . . 0.0 110.673 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -103.58 -19.25 14.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.074 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' HB ' ' A' ' 6' ' ' VAL . . . 100.21 18.88 20.55 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 20.2 m -95.53 136.97 35.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -1.143 . . . . 0.0 110.03 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' CYS . 1.4 mmtm -42.84 149.21 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.333 -0.854 . . . . 0.0 109.932 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -82.71 93.5 7.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.437 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 m -47.09 125.24 7.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -0.975 . . . . 0.0 109.661 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -116.95 136.62 52.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.038 -1.039 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -109.37 -7.21 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.89 168.92 25.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.405 -0.809 . . . . 0.0 109.912 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -84.3 -42.82 15.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.183 -0.948 . . . . 0.0 110.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 19.4 p-10 -56.5 -27.56 57.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 0.0 110.025 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 15.4 t80 -67.84 -50.83 54.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.83 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.1 m -70.38 -39.21 74.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.667 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 9.6 t70 -49.7 -52.47 31.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.398 -0.814 . . . . 0.0 109.681 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -64.7 -46.22 83.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.665 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HA ' ' HE2' ' A' ' 27' ' ' MET . 71.9 tp60 -59.53 -60.4 3.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 0.0 109.64 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 95.4 m -50.21 -51.42 44.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -43.04 -60.79 1.5 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.384 -0.822 . . . . 0.0 109.707 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.552 ' HE2' ' HA ' ' A' ' 24' ' ' GLN . 25.0 mtm -46.63 -36.38 6.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.609 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . 1.2 mmtm -84.22 42.85 0.9 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.858 . . . . 0.0 110.301 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER 41.33 32.48 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.323 -0.86 . . . . 0.0 110.656 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -93.82 166.73 12.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.179 -0.951 . . . . 0.0 109.885 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -39.44 3.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.897 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -112.83 85.62 0.4 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -102.37 113.33 4.57 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -146.53 -175.29 4.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.379 -1.071 . . . . 0.0 110.117 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -112.38 112.99 24.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 110.521 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -125.3 141.03 52.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.656 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 38' ' ' MET . . . 53.28 36.21 22.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 0.0 109.635 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 13.6 mmm 60.54 10.92 2.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.546 -0.722 . . . . 0.0 110.607 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 m -122.4 137.05 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 110.13 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' LEU . 4.7 t -66.19 145.83 55.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 0.0 110.257 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -145.6 116.7 7.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.293 -0.879 . . . . 0.0 109.96 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 14.7 m -106.11 139.87 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 110.351 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 33.8 tt0 -108.15 108.45 19.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.609 -0.682 . . . . 0.0 109.902 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.92 17.49 4.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 42' ' ' CYS . 84.9 mt -66.42 165.8 21.5 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.227 -1.161 . . . . 0.0 110.086 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.771 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -72.88 155.44 53.33 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.966 1.508 . . . . 0.0 110.186 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 8.9 tp10 -59.0 -23.83 62.26 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.211 -0.93 . . . . 0.0 110.737 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 48' ' ' ASN . 13.2 p30 -114.72 30.99 6.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.573 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.771 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -69.4 162.09 28.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.93 87.43 6.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG12 ' HA ' ' A' ' 5' ' ' PRO . 19.2 m -136.54 171.47 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.918 . . . . 0.0 110.269 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 t -90.13 123.33 33.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.101 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.89 5.16 16.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.193 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 4.5 p -117.76 126.1 51.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.113 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.82 -0.29 38.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.957 . . . . 0.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.1 53.7 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.127 -0.983 . . . . 0.0 110.272 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 57' ' ' ASN . 15.1 p-10 -109.07 174.48 5.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 0.0 109.894 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.8 mp -136.86 134.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.198 -0.939 . . . . 0.0 110.516 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.1 t -92.45 -139.64 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 110.015 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 117.971 -1.46 . . . . 0.0 109.514 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 13.0 pttt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.291 0.567 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.505 ' CG ' ' CG ' ' A' ' 43' ' ' GLU . 2.1 m-20 -105.18 148.43 26.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.758 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.81 -178.68 48.69 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.643 -1.265 . . . . 0.0 109.998 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 51' ' ' VAL . 63.9 m-85 -99.52 135.75 20.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.398 -1.06 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 46.7 Cg_endo -73.72 137.01 24.16 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.746 1.393 . . . . 0.0 110.054 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 50' ' ' LYS . 18.0 m -114.73 168.15 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -106.34 -169.93 1.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 110.112 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -66.39 -8.9 28.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.209 -0.932 . . . . 0.0 110.244 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -92.18 -26.78 18.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 110.207 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.98 21.89 8.7 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 60.8 m -114.33 136.56 52.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.24 -1.153 . . . . 0.0 109.931 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -62.46 160.8 12.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 tp -88.23 140.2 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.7 m -81.44 147.76 29.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.219 -0.926 . . . . 0.0 110.64 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 40' ' ' CYS . 32.1 p -112.74 135.08 53.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 109.933 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.589 HG12 ' HD2' ' A' ' 20' ' ' TYR . 11.6 p -110.49 -21.92 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.938 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 19' ' ' ASN . . . -152.9 165.25 36.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.949 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -73.5 -27.03 61.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 109.957 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 23.6 p-10 -75.78 -40.13 55.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.076 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HD2' HG12 ' A' ' 16' ' ' VAL . 1.1 t80 -56.57 -47.4 79.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 109.747 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -66.7 -42.19 86.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.73 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -45.72 -46.92 15.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.316 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' MET . 23.7 t-20 -70.57 -51.07 30.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.314 -0.866 . . . . 0.0 109.418 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' MET . 6.4 tp-100 -53.87 -54.93 31.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.513 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 97.2 m -55.76 -51.87 65.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.144 -0.973 . . . . 0.0 109.248 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -38.1 31.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.433 -0.792 . . . . 0.0 109.532 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.2 -40.69 90.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 109.682 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 14.0 mmmt -88.03 26.09 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.356 -0.84 . . . . 0.0 110.109 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.535 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 23.1 tttp 55.05 37.3 28.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.44 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -84.62 174.45 9.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.056 -1.028 . . . . 0.0 109.972 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -127.36 -14.52 5.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.617 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.29 82.72 0.26 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' CA ' ' SG ' ' A' ' 25' ' ' CYS . . . -94.9 125.29 8.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.413 ' CE1' ' HD2' ' A' ' 41' ' ' TYR . 7.2 p-80 -158.08 148.6 20.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -1.106 . . . . 0.0 109.979 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 22.0 t -86.58 122.94 31.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.13 -0.981 . . . . 0.0 110.807 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.658 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -146.04 141.72 27.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 109.868 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.658 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 65.16 22.35 12.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.839 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 71.83 6.16 5.56 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.418 -0.801 . . . . 0.0 110.485 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.4 m -124.83 154.18 41.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 110.116 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' CA ' ' HB3' ' A' ' 15' ' ' CYS . 7.9 t -81.08 130.27 34.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.097 -1.002 . . . . 0.0 110.471 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 52.4 t80 -127.54 120.67 28.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.401 -0.812 . . . . 0.0 109.978 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.597 ' HB2' HD11 ' A' ' 45' ' ' LEU . 39.7 m -106.86 136.44 46.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 110.03 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' CG ' ' CG ' ' A' ' 2' ' ' ASP . 10.8 tt0 -110.57 114.68 28.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.456 -0.778 . . . . 0.0 110.194 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.59 10.31 4.53 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 42' ' ' CYS . 71.7 mt -64.89 166.42 12.33 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.153 . . . . 0.0 110.097 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -70.89 150.28 61.08 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.903 1.475 . . . . 0.0 110.635 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 1.8 tm-20 -52.01 -21.4 3.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.422 -0.799 . . . . 0.0 110.929 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -113.66 26.27 10.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.014 -1.054 . . . . 0.0 110.907 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -63.9 157.59 24.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.987 -1.071 . . . . 0.0 109.913 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -93.38 94.18 8.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.79 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 31.4 m -138.61 173.56 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 110.575 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.1 t -90.31 158.12 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.44 -0.787 . . . . 0.0 110.209 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -110.58 12.83 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.986 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 p -109.53 126.32 53.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.178 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.33 -4.64 37.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 110.373 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.35 95.23 1.12 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.485 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 11.9 p-10 -150.89 170.47 19.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 109.85 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.56 150.63 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.056 -1.028 . . . . 0.0 110.612 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.1 p -121.97 -165.58 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.671 179.847 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.601 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 13.3 pttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.375 0.607 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 44' ' ' GLY . 10.7 m-20 -130.32 170.03 14.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.85 . . . . 0.0 109.769 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.44 -160.91 33.18 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.569 -1.301 . . . . 0.0 109.91 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 41' ' ' TYR . 65.0 m-85 -117.83 123.61 29.51 Favored Pre-proline 0 C--N 1.299 -1.595 0 O-C-N 121.715 -0.874 . . . . 0.0 109.514 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.6 Cg_endo -71.59 139.02 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.788 1.415 . . . . 0.0 110.313 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 50' ' ' LYS . 33.3 m -100.48 -179.58 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 110.129 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 11' ' ' CYS . 1.0 OUTLIER -108.45 -168.23 1.33 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.421 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 p -59.22 -13.19 6.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 0.0 110.991 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -106.06 -16.4 14.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.021 -1.05 . . . . 0.0 110.601 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.3 0.22 47.24 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.492 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . 67.9 m -80.47 142.53 34.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -1.175 . . . . 0.0 109.988 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.502 ' CD ' ' OD1' ' A' ' 57' ' ' ASN . 22.1 mtpt -56.9 137.94 54.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.349 -0.844 . . . . 0.0 110.334 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.815 HD21 ' OH ' ' A' ' 20' ' ' TYR . 21.8 tp -79.58 109.98 14.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.234 -0.916 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 38' ' ' MET . 5.7 m -59.86 138.86 57.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.9 . . . . 0.0 110.162 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 23.8 p -104.98 136.55 44.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.122 -0.986 . . . . 0.0 109.81 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.8 p -113.93 -17.17 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 110.43 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.757 ' HB1' ' ND2' ' A' ' 19' ' ' ASN . . . -151.2 131.62 13.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.376 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 -54.14 -29.61 45.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 110.076 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.757 ' ND2' ' HB1' ' A' ' 17' ' ' ALA . 19.3 p30 -70.17 -41.25 74.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 110.2 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.815 ' OH ' HD21 ' A' ' 13' ' ' LEU . 3.8 t80 -59.32 -51.58 69.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 109.512 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.1 m -61.87 -33.36 74.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 39.8 t0 -57.93 -59.12 5.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.91 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -62.01 -37.81 86.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.245 -0.909 . . . . 0.0 109.822 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' MET . 0.2 OUTLIER -68.24 -62.08 1.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.893 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' HA3' ' A' ' 33' ' ' GLY . 62.7 m -45.29 -47.83 13.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.279 -0.888 . . . . 0.0 109.658 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.8 tttt -57.54 -41.96 81.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 21.5 mtm -62.12 -31.46 71.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 109.647 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 29.1 mmtp -87.54 15.12 7.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.38 -0.825 . . . . 0.0 109.894 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 25.7 tttt 69.47 54.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.429 -0.795 . . . . 0.0 110.524 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.561 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -118.9 161.06 20.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.0 110.226 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.09 -27.29 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 110.123 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -123.37 77.83 0.36 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.544 ' HA3' ' CB ' ' A' ' 25' ' ' CYS . . . -91.07 122.49 6.73 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' ' C ' ' A' ' 34' ' ' HIS . 2.4 p-80 -159.05 154.73 26.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.134 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 8.2 t -79.68 137.67 37.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 110.254 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -153.19 139.86 18.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.452 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.88 39.67 29.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.303 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER 59.28 14.29 3.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.835 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -132.58 137.26 47.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.891 . . . . 0.0 110.062 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 5.1 t -65.89 134.83 53.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 110.476 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 89.9 t80 -131.83 124.63 29.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HB3' ' CB ' ' A' ' 30' ' ' ALA . 20.8 m -113.87 136.43 52.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.521 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB3' ' HA3' ' A' ' 32' ' ' GLY . 21.8 tt0 -106.54 105.93 16.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 109.762 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 2' ' ' ASP . . . 136.51 -1.97 3.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.019 HD13 HG11 ' A' ' 51' ' ' VAL . 8.8 mt -48.42 163.11 0.32 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.086 -1.244 . . . . 0.0 109.995 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.794 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.8 Cg_endo -72.22 143.73 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.885 1.466 . . . . 0.0 110.353 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 25.6 tt0 -45.6 -25.72 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 48' ' ' ASN . 52.0 p30 -111.63 31.73 5.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.794 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -68.49 158.79 33.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 110.365 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -94.25 71.5 3.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 0.0 109.784 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.019 HG11 HD13 ' A' ' 45' ' ' LEU . 29.6 m -120.9 172.34 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.303 -0.873 . . . . 0.0 110.542 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.6 t -86.62 136.44 33.04 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 0.0 109.901 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -85.81 23.41 1.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.406 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -153.57 135.45 14.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 110.452 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' O ' ' NZ ' ' A' ' 12' ' ' LYS . . . -69.56 -5.23 23.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.405 -0.81 . . . . 0.0 110.023 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 m -141.84 107.2 5.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.873 . . . . 0.0 110.328 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.502 ' OD1' ' CD ' ' A' ' 12' ' ' LYS . 13.6 p-10 -143.84 174.71 10.58 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.44 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 91.7 mt -138.52 153.05 25.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.352 -0.842 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 25.6 p -140.82 83.9 1.91 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.983 . . . . 0.0 110.192 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 117.993 -1.448 . . . . 0.0 109.542 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 45' ' ' LEU . 1.4 pttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.252 0.549 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' CG ' ' HG3' ' A' ' 43' ' ' GLU . 2.5 m-20 -101.09 160.04 14.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 109.659 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.1 -167.2 39.16 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.365 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.572 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 17.2 m-85 -108.33 133.73 20.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.585 -0.95 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HA ' HG12 ' A' ' 51' ' ' VAL . 48.4 Cg_endo -74.61 139.76 25.78 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.863 1.454 . . . . 0.0 110.948 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' O ' ' A' ' 50' ' ' LYS . 16.7 m -117.93 171.3 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.369 -0.832 . . . . 0.0 109.582 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 57.9 p30 -106.64 -174.81 2.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 110.466 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.1 p -57.51 -20.68 33.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 110.316 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -86.7 -26.63 24.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.976 . . . . 0.0 110.031 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 108.65 3.26 32.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.4 m -86.94 136.98 32.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.904 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -63.21 153.54 34.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 0.0 110.23 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 tp -79.8 101.15 8.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 38' ' ' MET . 35.8 m -51.05 161.72 0.36 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.409 ' SG ' ' C ' ' A' ' 39' ' ' SER . 24.8 p -142.91 143.8 32.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -0.946 . . . . 0.0 110.552 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.28 -19.99 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.347 -0.846 . . . . 0.0 109.896 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.34 164.09 31.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.377 -0.827 . . . . 0.0 110.016 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 19' ' ' ASN . 33.6 m-20 -78.95 -47.98 15.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 6.0 p30 -44.69 -35.44 2.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.133 -0.98 . . . . 0.0 109.588 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 85.9 t80 -52.15 -56.92 11.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 0.0 110.064 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 84.6 m -68.55 -37.11 79.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.404 -0.81 . . . . 0.0 110.574 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -47.04 -64.87 0.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.787 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -66.15 -52.96 43.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 110.937 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 25' ' ' CYS . 17.0 tp60 -51.99 -63.85 1.01 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.948 -1.095 . . . . 0.0 110.035 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' GLN . 89.9 m -43.41 -54.63 4.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.68 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -47.94 -49.74 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.2 mmm -53.25 -30.4 38.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 0.0 110.039 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' LYS . 3.8 mmpt? -88.94 29.0 1.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.17 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 38.0 ttmt 67.1 4.83 3.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.493 -0.754 . . . . 0.0 110.915 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.22 -179.86 7.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 0.0 110.175 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.69 -37.9 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 110.128 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 84.9 0.77 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.53 116.31 5.46 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' CE1' ' CD2' ' A' ' 41' ' ' TYR . 9.3 p-80 -150.49 147.03 27.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.123 . . . . 0.0 110.316 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.1 t -84.29 138.36 32.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.349 -0.844 . . . . 0.0 110.496 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -156.86 151.27 25.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.87 . . . . 0.0 109.916 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 50.58 33.77 8.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 109.89 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 7.3 ttt 65.87 10.88 7.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 110.372 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 35.2 m -128.63 147.07 50.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.5 t -75.93 154.03 36.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.314 -0.866 . . . . 0.0 110.088 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' CD1' ' CZ ' ' A' ' 4' ' ' TYR . 59.3 t80 -145.21 129.06 17.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.193 -0.942 . . . . 0.0 110.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.9 m -117.4 142.42 47.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.932 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.449 ' HG3' ' CG ' ' A' ' 2' ' ' ASP . 16.9 tt0 -110.41 101.22 9.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.395 -0.815 . . . . 0.0 110.158 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.75 24.25 0.75 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 42' ' ' CYS . 47.3 mt -79.38 161.52 67.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.305 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 43.9 Cg_endo -73.0 140.76 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.956 1.503 . . . . 0.0 110.221 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -53.18 -32.09 46.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.192 -0.942 . . . . 0.0 110.674 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 46' ' ' PRO . 24.1 p30 -81.52 6.43 14.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -73.88 156.51 37.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 109.862 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.756 ' O ' HG22 ' A' ' 6' ' ' VAL . 16.6 tptt -96.58 108.78 21.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.821 . . . . 0.0 110.221 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 27.2 m -143.7 165.1 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.928 . . . . 0.0 110.562 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 t -91.19 122.15 33.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.507 -0.746 . . . . 0.0 109.663 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 20.7 p-10 -86.13 31.95 0.63 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.127 -0.983 . . . . 0.0 110.365 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p -157.68 153.82 27.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.86 -3.57 29.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.285 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.3 m -85.62 141.44 29.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' OD1' ' A' ' 57' ' ' ASN . 12.7 p30 -87.17 152.57 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.212 -0.93 . . . . 0.0 110.42 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 58' ' ' ILE . 3.0 tt -131.59 51.54 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 109.924 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 t -89.29 41.58 1.04 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.572 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 47' ' ' GLU . 2.3 pttt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.36 0.6 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.467 ' OD1' ' HG3' ' A' ' 43' ' ' GLU . 3.2 m-20 -103.94 140.55 37.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 109.112 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.485 ' C ' ' CE1' ' A' ' 41' ' ' TYR . . . -167.1 -174.7 36.52 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.468 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' HB ' ' A' ' 51' ' ' VAL . 97.9 m-85 -103.61 122.17 45.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.434 -1.039 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.678 ' HA ' HG12 ' A' ' 51' ' ' VAL . 44.7 Cg_endo -72.06 138.04 30.17 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.71 1.374 . . . . 0.0 109.929 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -108.73 174.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.336 -0.853 . . . . 0.0 110.59 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' OD1' ' HB3' ' A' ' 9' ' ' LYS . 53.4 p-10 -107.86 179.75 4.14 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.627 -0.671 . . . . 0.0 109.747 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.7 p -49.88 -22.39 1.48 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.15 -0.969 . . . . 0.0 109.942 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 7' ' ' ASP . 16.4 ttmt -81.2 -25.97 36.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.424 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.21 4.56 55.17 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.0 m -98.97 145.21 27.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 110.124 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -55.3 144.42 24.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 110.159 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.653 HD21 ' OH ' ' A' ' 20' ' ' TYR . 14.1 tp -79.54 134.53 36.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -70.61 140.26 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.145 -0.972 . . . . 0.0 109.958 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 24.4 p -122.99 143.11 50.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 110.509 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p -123.78 -27.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.896 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.81 149.21 50.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 109.754 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -71.61 -24.91 61.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 0.0 110.126 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 13.3 p30 -74.97 -42.02 58.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.306 -0.871 . . . . 0.0 110.511 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.653 ' OH ' HD21 ' A' ' 13' ' ' LEU . 1.7 t80 -53.95 -50.5 66.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.059 -1.025 . . . . 0.0 109.67 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.3 m -66.53 -44.37 82.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 0.0 109.554 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -48.79 -33.35 10.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.862 . . . . 0.0 109.515 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -72.5 -57.86 3.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' MET . 33.0 tp60 -51.45 -58.35 6.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HA2' ' A' ' 33' ' ' GLY . 68.0 m -46.64 -57.0 5.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.916 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -42.11 -45.21 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.342 -0.849 . . . . 0.0 110.129 179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 2.0 mtm -63.98 -31.03 72.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 5' ' ' PRO . 8.7 mttm -86.92 20.53 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.185 -0.947 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 68.32 29.56 5.87 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.26 -0.9 . . . . 0.0 110.599 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -102.39 159.26 15.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.167 -0.958 . . . . 0.0 109.863 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.6 m -114.4 -24.93 8.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.923 . . . . 0.0 110.367 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 43' ' ' GLU . . . -112.69 78.33 0.25 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' SG ' ' A' ' 25' ' ' CYS . . . -96.85 123.98 7.95 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -159.93 -175.79 5.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -1.105 . . . . 0.0 110.257 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' CYS . 20.4 t -100.92 124.98 47.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.858 . . . . 0.0 109.592 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -125.19 128.98 49.2 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 110.815 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 38' ' ' MET . . . 48.54 46.13 20.99 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.411 -0.806 . . . . 0.0 110.712 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.445 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 65.86 7.07 4.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.208 -0.933 . . . . 0.0 110.418 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 74.5 m -124.66 139.94 53.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.078 -1.014 . . . . 0.0 110.161 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 5' ' ' PRO . 4.2 t -63.33 140.75 58.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.016 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' CE1' ' C ' ' A' ' 3' ' ' GLY . 7.1 t80 -141.87 135.86 29.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 110.372 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.858 ' HB2' HD11 ' A' ' 45' ' ' LEU . 17.4 m -122.25 142.6 50.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.252 -0.905 . . . . 0.0 110.03 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HG3' ' OD1' ' A' ' 2' ' ' ASP . 4.4 tt0 -113.77 111.67 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.48 -0.762 . . . . 0.0 110.441 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.91 11.25 4.93 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD11 ' HB2' ' A' ' 42' ' ' CYS . 92.3 mt -68.03 164.32 42.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.178 -1.189 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 42.3 Cg_endo -70.74 144.3 48.42 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.37 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 29.0 tt0 -47.93 -22.52 0.59 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 111.182 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -111.48 24.84 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . . . -58.21 160.97 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.61 74.95 9.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 110.499 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.678 HG12 ' HA ' ' A' ' 5' ' ' PRO . 33.8 m -134.49 170.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.133 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -85.24 158.37 20.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 21.4 p-10 -115.47 14.49 16.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.15 -0.969 . . . . 0.0 110.467 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 p -121.74 115.39 22.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.129 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.5 5.69 12.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.39 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 56' ' ' THR . 8.6 t -140.74 65.51 1.4 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.116 -0.99 . . . . 0.0 110.442 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -144.8 161.23 39.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.262 -0.899 . . . . 0.0 110.233 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.15 133.77 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.393 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.4 p -103.82 147.36 27.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.543 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.508 ' HE2' ' HB3' ' A' ' 49' ' ' ALA . 5.0 pttt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.23 0.538 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -104.04 167.44 9.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.131 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.83 -167.95 38.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.7 m-85 -113.75 126.22 28.4 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.47 -1.018 . . . . 0.0 109.25 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' A' ' 51' ' ' VAL . 42.9 Cg_endo -69.69 136.7 33.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.732 1.385 . . . . 0.0 109.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 50' ' ' LYS . 34.8 m -101.12 174.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 O-C-N 121.426 -0.796 . . . . 0.0 110.441 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 10' ' ' GLY . 26.2 p-10 -94.46 -175.39 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 109.949 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 p -56.8 -16.05 5.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.903 . . . . 0.0 111.008 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.42 -27.93 13.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.993 -1.067 . . . . 0.0 110.691 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' N ' ' OD1' ' A' ' 7' ' ' ASP . . . 121.95 -3.7 10.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 83.9 m -79.28 137.21 37.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.147 -1.207 . . . . 0.0 110.242 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE2' ' OD1' ' A' ' 57' ' ' ASN . 13.5 mtmt -51.63 149.4 4.54 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.393 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 10.9 tp -89.84 104.68 17.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.451 -0.781 . . . . 0.0 109.819 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 38' ' ' MET . 3.7 m -70.08 143.03 52.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 110.409 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.9 p -136.6 165.61 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -0.84 . . . . 0.0 110.282 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.8 p -130.85 16.65 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 110.086 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 35' ' ' CYS . . . -158.83 161.93 36.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 110.105 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -85.94 -38.87 17.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 20' ' ' TYR . 34.2 p-10 -58.7 -45.78 88.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.991 -1.068 . . . . 0.0 110.238 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 23.2 t80 -46.79 -56.76 5.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.041 -1.037 . . . . 0.0 109.62 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.5 m -69.14 -33.91 74.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.878 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -50.52 -49.63 55.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -71.46 -50.89 27.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.897 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.0 tp60 -49.54 -65.44 0.56 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.666 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 28' ' ' LYS . 72.9 m -46.82 -53.55 11.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.817 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 25' ' ' CYS . 38.6 ttmt -44.19 -55.87 4.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.81 . . . . 0.0 109.698 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -26.03 27.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.7 mttm -89.45 19.41 4.51 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.343 -0.848 . . . . 0.0 109.844 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 5.5 tttt 60.49 39.12 18.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.418 -0.802 . . . . 0.0 110.508 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 42' ' ' CYS . . . -109.48 167.05 10.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.094 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.49 -41.7 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.903 . . . . 0.0 110.323 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -103.06 89.05 0.68 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' SG ' ' A' ' 25' ' ' CYS . . . -114.81 113.17 2.91 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -154.11 -171.41 3.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -1.086 . . . . 0.0 110.204 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 7.4 t -108.42 126.85 53.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 0.0 110.479 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.681 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 1.2 t80 -141.97 129.08 20.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.866 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 66.85 30.04 8.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.145 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.512 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 69.37 5.78 5.33 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.2 -0.938 . . . . 0.0 110.415 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.92 142.45 50.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.11 -0.994 . . . . 0.0 110.171 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.98 155.53 40.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 109.954 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -156.88 131.56 8.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 110.646 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.558 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.6 m -118.58 143.63 46.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.353 -0.842 . . . . 0.0 109.941 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -112.71 102.99 11.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.404 -0.81 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 128.35 13.61 2.57 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 51' ' ' VAL . 33.9 mt -59.81 165.33 4.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.019 -1.283 . . . . 0.0 109.931 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 49' ' ' ALA . 45.4 Cg_endo -73.13 172.2 16.02 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.866 1.456 . . . . 0.0 110.644 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 1' ' ' LYS . 51.9 tt0 -69.72 -19.25 63.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 110.4 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.416 ' C ' ' OD1' ' A' ' 48' ' ' ASN . 11.8 p30 -106.97 18.41 21.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 110.798 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.508 ' HB3' ' HE2' ' A' ' 1' ' ' LYS . . . -58.03 155.69 10.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.952 -1.092 . . . . 0.0 109.803 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 6' ' ' VAL . 4.8 ttmm -103.53 74.87 1.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.794 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 45' ' ' LEU . 17.8 m -123.45 170.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 110.47 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.3 t -90.37 121.95 32.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.406 -0.809 . . . . 0.0 110.09 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 53' ' ' ASP . 14.3 p-10 -87.67 28.5 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 0.0 110.072 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 57' ' ' ASN . 86.8 p -132.59 95.61 3.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.998 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.38 -18.19 3.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.941 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -120.43 82.08 1.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 1.3 p-10 -145.78 172.33 13.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.225 -0.922 . . . . 0.0 110.088 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.427 HG12 ' N ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -139.92 155.9 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.133 -0.98 . . . . 0.0 110.459 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 58' ' ' ILE . 6.3 t -137.51 132.5 33.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.364 -0.835 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 45' ' ' LEU . 47.0 pttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.267 0.556 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.52 ' CB ' ' OH ' ' A' ' 41' ' ' TYR . 7.9 m-20 -115.7 137.81 51.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.123 -0.986 . . . . 0.0 109.809 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.11 -170.24 38.58 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.04 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 4' ' ' TYR . 29.1 m-85 -106.95 122.44 41.61 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.432 -1.04 . . . . 0.0 110.138 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.825 ' HA ' HG12 ' A' ' 51' ' ' VAL . 43.5 Cg_endo -70.97 140.7 38.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.864 1.455 . . . . 0.0 110.137 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 50' ' ' LYS . 14.8 m -111.03 177.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.764 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 47.4 p-10 -85.21 -172.74 4.32 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.645 -0.659 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.6 p -61.92 -12.52 18.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.223 -0.923 . . . . 0.0 109.93 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 -32.19 17.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 110.553 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 6' ' ' VAL . . . 119.29 -6.81 12.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 6' ' ' VAL . 44.4 m -79.93 143.79 33.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.165 -1.197 . . . . 0.0 110.049 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HA ' HG12 ' A' ' 6' ' ' VAL . 42.9 mtpt -56.48 157.14 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.922 . . . . 0.0 110.268 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.574 HD21 ' OH ' ' A' ' 20' ' ' TYR . 62.2 tp -94.09 121.45 35.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 110.197 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.9 m -64.88 127.58 32.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.58 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.9 p -111.9 138.83 47.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.103 -0.998 . . . . 0.0 110.693 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.62 -19.1 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.456 -0.777 . . . . 0.0 109.464 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.1 164.04 28.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.492 -0.755 . . . . 0.0 110.139 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -86.07 -52.74 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -0.896 . . . . 0.0 110.138 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 5.4 p-10 -46.77 -39.71 12.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 110.198 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' OH ' HD21 ' A' ' 13' ' ' LEU . 59.1 t80 -57.2 -50.79 71.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.138 -0.976 . . . . 0.0 109.92 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.5 m -64.97 -41.39 95.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 47.8 t0 -51.86 -36.73 49.46 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -72.11 -60.48 2.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.833 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' MET . 47.7 tp60 -47.48 -56.16 7.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 30' ' ' ALA . 60.6 m -52.97 -57.52 10.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.342 -0.849 . . . . 0.0 109.809 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 17.6 ttpt -46.02 -46.75 16.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.367 -0.833 . . . . 0.0 109.946 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -53.17 -38.44 62.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.596 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -88.49 21.11 3.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.782 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.2 tttm 60.66 49.62 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 110.722 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . . . -103.22 167.98 9.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.163 -0.961 . . . . 0.0 109.418 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.6 OUTLIER -115.55 -30.92 6.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.936 -1.102 . . . . 0.0 110.843 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 42' ' ' CYS . . . -118.53 86.56 0.41 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 41' ' ' TYR . . . -105.19 106.4 2.66 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -144.5 171.89 13.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.994 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.0 t -99.67 124.49 44.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.201 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -145.35 140.12 27.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 109.93 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 36' ' ' TYR . . . 62.78 35.62 13.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.143 -0.973 . . . . 0.0 110.086 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 4.9 mmt 57.96 16.59 3.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.374 -0.829 . . . . 0.0 110.223 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -134.65 142.57 46.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.0 110.048 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.6 t -69.29 151.45 46.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.52 ' OH ' ' CB ' ' A' ' 2' ' ' ASP . 70.6 t80 -147.72 147.13 29.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.205 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 13.1 m -134.09 141.47 47.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 110.134 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' HA ' ' OD1' ' A' ' 2' ' ' ASP . 2.3 tt0 -104.35 97.95 7.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.112 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.63 23.81 1.82 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 51' ' ' VAL . 13.1 mt -63.21 167.29 6.69 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.136 -1.214 . . . . 0.0 109.991 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.8 ' HG2' ' HB2' ' A' ' 49' ' ' ALA . 46.2 Cg_endo -73.77 146.39 38.06 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.974 1.512 . . . . 0.0 110.169 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -57.55 -17.69 15.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 110.571 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' A' ' 46' ' ' PRO . 0.4 OUTLIER -109.24 17.31 21.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.091 -1.005 . . . . 0.0 110.706 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.8 ' HB2' ' HG2' ' A' ' 46' ' ' PRO . . . -69.6 157.74 36.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.006 . . . . 0.0 109.95 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -99.0 95.19 6.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.298 -0.876 . . . . 0.0 110.178 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG12 ' HA ' ' A' ' 5' ' ' PRO . 34.6 m -134.43 168.89 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 110.522 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.8 t -81.82 144.78 30.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.352 -0.842 . . . . 0.0 109.755 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -96.92 7.31 46.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.142 -0.974 . . . . 0.0 110.455 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 p -134.46 144.4 48.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -28.92 40.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -91.72 145.57 24.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.536 -0.728 . . . . 0.0 110.086 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -83.64 122.47 28.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.332 -0.855 . . . . 0.0 110.23 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 mm -106.96 63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.188 -0.945 . . . . 0.0 110.147 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.89 29.29 7.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.212 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 CA-C-O 118.019 -1.434 . . . . 0.0 109.614 179.996 . . . . . . . . 0 0 . 1 stop_ save_